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ABSTRACT
In recent years, nanomaterials have demonstrated their potential to enhance the sensitivity and
utility of biosensors due to their superior electrical and mechanical properties. Specifically,
carbon-based nanomaterials, such as carbon nanotubes (CNTs) and graphene have proven their
practicality over other nanomaterials because of their low-cost, wide availability, high surface-tovolume ratio, and potential biocompatibility, to name a few. These nanomaterials when
incorporated with biosensing devices are expected to enhance the critical sensing performances of
the biosensors. Therefore, in this dissertation, these carbon nanomaterials are utilized to build
nanoelectronic devices for highly sensitive and selective detection of protein biomarkers—
biological molecules expressed in response to diseases like cancer, malaria, AIDS, Alzheimer’s,
etc. Graphene when used in field-effect transistor (FET) configuration has shown to be effective
in biosensing. However, such graphene FET (GFET)-based biosensors suffer from several
drawbacks, limiting their performances and usage. Thus, most of the work in my dissertation
focuses on the development of graphene FET (GFET)-based biosensors for protein detection as
well as the enhancement of performances by optimizing electrode design and integrating to
microfluidics. The novelty of this work lies in the first detection of lysozyme, a model protein
biomarker, with a limit of detection in the clinically relevant range. Moreover, this GFET platform
is further advanced by integrating to microfluidics platform where real-time sensing of another
protein biomarker, namely thrombin, is demonstrated with the lowest limit of detection reported
so far with GFET.

For selective detection, biosensors are often equipped with a recognition element,
alternatively known as the bioreceptor. Aptamers were used throughout this work because they
offer a number of unique properties that make them a suitable candidate with respect to its
counterparts such as antibodies and enzymes. Sensing performances and applicability of the
sensors often depend on the proper functionalization of aptamers on the sensing surfaces.
Therefore, this dissertation also focuses on the development of novel aptamer immobilization
methods to enhance reproducibility, automation, as well as rapid, easy and mass-scale production.
Besides GFET-based biosensors, a disposable low-cost electrochemical biosensor was also
developed for the selective detection of lysozyme protein. The main goal of the project is to explore
the feasibility of using inkjet-printing as a novel means for aptamer immobilization on electrodes.
xxiv

CNTs mixed with aptamers at a certain ratio not only enhances the printability of the ink, but also
augments the conductivity of the electrode. With this printing-based novel aptamer immobilization
method, the detection of lysozyme was demonstrated with the sensitivity comparable to other
conventional methods.

Finally, the flexibility of graphene is exploited to build a flexible GFET envisioned for
wearable biosensor. To avoid the expensive and sophisticated microfabrication, the electrodes are
printed with conductive silver ink on a flexible substrate. Kapton®, a polyimide film is chosen
because of its flexibility, chemical and thermal stability. With this Kapton-based flexible GFET
sensor, a real-time detection of interleukin-6 (IL-6) protein, a well-known cytokine and a key
biomarker for various immune responses, was demonstrated for the first time.

In summary, the dissertation provides guidelines and insights for the development of highly
sensitive nanoelectronic devices envisioned for a low-cost, highly reproducible, rapid, portable,
and miniaturized biosensor for healthcare monitoring. In particular, this research sheds light on the
feasibility of using carbon nanotubes (CNTs) and graphene for the exciting new applications in
the field of biosensing.
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INTRODUCTION
1.1.

Motivation

In ancient times, healthcare used to be provided at the patient’s side – doctors used to visit the
patients with whatever medical diagnostic tools they had to treat their patients (Figure 1.1). But
with the advent of modern sophisticated and bulky medical instruments, healthcare has transferred
from the patient’s side to remote hospitals and diagnostic centers (Figure 1.2A). Nowadays,
patients are required to visit a hospital or a clinic to receive healthcare. However, the situation
becomes an issue in the developing countries where there is a shortage of enough hospitals and
clinics as well as lack of proper means of transportation.

Figure 1.1. Healthcare system in ancient times. Doctors used to visit the patients to diagnose their
diseases. (Source: www.chinesemedicalnews.com)
Recently, there has been a concerted effort to bring the healthcare back to the patient’s side, where
visiting a hospital or a doctor may be less frequent, thanks to the progress in miniaturization and
portable technology that led to the development of point-of-care (POC) diagnostic devices. One of
the examples of commercialized POC devices is the glucose sensor (Figure 1.2B) to monitor and
quantify the sugar level in blood at home.
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Figure 1.2. Transformation towards point-of-care: (A) bulky laboratory setup located at remote
hospitals and clinics, and (B) the glucose POC device used to monitor and quantify sugar level in
the blood.

One of the major components of these POC devices is the biosensor. Other applications of
biosensors are drug delivery, environmental monitoring, soil quality monitoring, food quality
monitoring, toxins of defense interest, water quality management, and prosthetic devices as
illustrated in Figure 1.3. Due to the versatile applications of biosensors, the research on biosensors
has been constantly boosting up, as seen by the exponential increase in the number of publications

Figure 1.3. Applications of biosensors in different fields.
2

with a keyword ‘biosensor’ as presented in Figure 1.4A. Figure 1.4B shows the global market for
biosensors that is quite large and is only expected to grow in the coming years as interest in food
quality, health care monitoring, disease diagnostics, and national security continue to grow.

Figure 1.4. Graphs showing (A) the number of publications on the keyword “biosensor” during
the period 1980 to 2011, and (B) the world market for biosensors estimated from various
commercial sources. Adapted from [1].

1.2.

Thesis Overview

The purpose of this thesis is to offer insight into the emerging technology in the development of
biosensors. The focus of the thesis is to explore the field of nanoelectronics and nanoelectronic
devices to enhance the sensitivity of nanobiosensors as well as to solve issues in conventional
methods for functionalizing bioreceptors. Nanoelectronics which can simply be defined as the
electronics of nanomaterials, are particularly important for biosensors because of the versatile
advantages they incorporate to the sensing systems, such as high selectivity and sensitivity,
biocompatibility, miniaturization, etc. Among different nanomaterials, carbon nanomaterials such
as carbon nanotube and graphene provide exciting new opportunities for biosensing applications
due to their extraordinary electrical and mechanical properties.

In this thesis, CNTs are used to develop an electrochemical biosensor for the detection of lysozyme
protein which can act as a biomarker for a number of diseases such as breast cancer, Alzheimer’s,
rheumatoid arthritis, malaria, etc. Herein, we also explore the possibility of using inkjet-printing
to fabricate this biosensor by depositing CNT on the electrode. The concept of inkjet-printing has
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been around for quite some time, but recently it has attracted much attention as a deposition
technique due to its several advantages such as controllability of deposited ink with great precision,
rapid and automated printing process at low-cost, printability of multiple materials simultaneously
as well as easy development of microarrays. Moreover, inkjet-printing is an “additive”
manufacturing technique as opposed to the “subtractive” manufacturing techniques like
lithography, that significantly reduces the amount of material wastage.

Upon completion of this inkjet-printed CNT biosensor, another new carbon nanomaterial graphene
is exploited to develop a field-effect transistor (FET) biosensor which is later integrated to
microfluidics to extract the combined advantages of graphene and microfluidics, such as high
sensitivity, flexibility, and compatibility with lab-on-a-chip devices.

The next goal is to push this GFET detection platform further towards flexible electronics to
develop wearable biosensors, which are non-invasive devices that can be worn or mated with the
human skin to continuously and closely monitor an individual’s activities without interrupting or
limiting the user’s daily routine. To develop this flexible GFET, a flexible substrate is used to
replace the rigid SiO2/Si substrate. Here, I use Kapton®, a polyimide film as the flexible substrate
due to the advantages it offers. To avoid the high cost and complexity in microfabrication,
electrodes are formed by simply printing commercially available conductive silver ink on the
flexible substrate.

1.3.

Thesis Outline

This thesis presents the development and application of nanoelectronic devices for biosensing
specially protein sensing. A major part of this thesis focuses on the development and application
of GFET devices for detection of protein biomarkers. Apart from GFET-based biosensing, a novel
inkjet-printed electrochemical biosensor is developed and applied for sensing of protein. To
accommodate them along with the theoretical background, the thesis is divided into nine chapters.

Chapter 2 provides the theoretical background of biosensors—definition, history and evolution,
and classification of biosensors of particular interest. A brief introduction to aptamers as
recognition elements as well as to proteins as biomarkers is also presented. Chapter 3 presents the
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background for carbon-based nanoelectronics, especially the electronics of two popular carbon
nanomaterials, namely CNT and graphene.

Chapter 4 describes the development of the novel inkjet-printed biosensor. The chapter presents
the detailed protocol for the CNT-aptamer ink preparation, characterization and measurements as
well as discusses the results.

Chapter 5, 6 and 7 are built on the development and application of GFET-based sensors.
Specifically, Chapter 5 describes the first detection of lysozyme protein with a nanomolar limit of
detection. Chapter 6 further advances this GFET platform by integrating with microfluidics and
demonstrates the sensing of another protein thrombin with picomolar limit of detection—lowest
among the other GFET-based thrombin sensors reported so far. Chapter 7 discusses the extension
of this rigid GFET to a flexible platform and presents the development of this flexible GFET on a
polyimide film along with the demonstration of the real-time detection of a sweat-based protein,
namely interleukin-6 (IL-6).

Chapter 8 presents a novel aptamer immobilization method on GFET platform where
commercially available amine-linked aptamers are preconjugated with pyrene group and this
pyrene tagged aptamers, soluble in water-based solvents, are exposed to GFETs. This chapter
discusses the detailed process and characterization of the preconjugation as well as the
measurement results showing the sensing of IL-6 protein as a representative analyte.

Finally, Chapter 9 presents the concluding remarks as well as future work.
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CHAPTER 2: FUNDAMENTALS OF BIOSENSORS
2.1.

What is a Biosensor?

According to the definition of International Union for Pure and Applied Chemistry (IUPAC), a
biosensor is a self-contained integrated device which is capable of providing specific quantitative
or semi-quantitative analytical instrumentation using a biological recognition element
(biochemical receptor) in direct spatial contact with a transducer element [1]. It can simply be
viewed as a device that converts a physical or biological event into a measurable signal. As can be
seen in Figure 2.1, it consists of three main parts: (1) a biorecognition molecule or a bioreceptor
(aptamer, tissue, microorganism, organelle, cell receptors, enzyme, antibody, protein, etc.) which
is a biologically derived material or biomimetic component that provides selectivity to the target
analyte, (2) a transducer (physicochemical, optical, piezoelectric, electrochemical, etc.) that
converts the resulting signal from the interaction of the analyte to the biosensing element into a
measurable and quantifiable signal (in most cases electrical signal), and (3) the associated
electronics or data analysis system which is primarily responsible for signal processing and userfriendly visualization of the sensing results.

Figure 2.1. Schematic illustration showing different parts of a biosensor: (a) biorecognition
elements, (b) transducers, and (d) data analysis system. Reproduced from [2].
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There are several classes of bioreceptors with distinct structures that uniquely affect the biosensor
performance. These numerous bioreceptors can be categorized into two main types -- natural and
synthetic. Natural bioreceptors, such as antibodies and enzymes, are biologically derived
constructs that take advantage of naturally evolved physiological interactions to achieve analyte
specificity. On the other hand, synthetic bioreceptors, such as aptamers and molecularly imprinted
polymers (MIPs) are artificially engineered structures developed to mimic physiologically defined
interactions [3].

2.2.

History and Evolution of Biosensors

The history of biosensors dates back to the 1950s, when Leland Clark Jr. invented the first and
foremost electrochemical oxygen biosensor in 1956. Known as the Clark oxygen electrode, it
consisted of a sliver/silver chloride reference electrode and a platinum cathode at which oxygen
was reduced [4]. This oxygen electrode was later combined by Clark and Lyons with glucose
oxidase incorporated in a dialysis membrane to measure the concentration of glucose in solution
[5]. A couple of years later in 1967, Updike and Hicks described the first “enzyme electrode” for
in vitro quantification of glucose in solution and in tissues. The electrode was engineered through
immobilization of glucose oxidase in a polymerized gelatinous membrane that coated a
polarographic oxygen electrode, thus serving as an enzyme transducer to catalyze an
electrochemical reaction upon recognition of glucose [5].

Later in 1969, the first potentiometric enzyme electrode was developed by Guilbault and Montalvo
to realize a urea sensor based on the immobilization of urease onto an ammonium-selective liquid
membrane electrode [6]. Since then, a broad range of biosensors have been developed for in vitro
and in vivo applications, whose nature ranges from enzymatic, to antibody, polypeptide, aptamer,
or nucleic acids-based. Similarly, the evolution of a variety of transduction mechanisms has
diversified the field of biosensors, ranging from electrochemical and electronic biosensors to
thermic biosensors that measure the changes in temperature associated with the amount of heat
generated by an enzyme-catalyzed reaction; microbial biosensors which integrate microorganisms with a physical transducer, such as an electrochemical device, to monitor specific
analytes or biomarkers typically through the production of electroactive metabolites;
immunobiosensors based on recognition of target species by recombinant antibodies or antibody
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fragments; optical biosensors, based on the differences in optical diffraction or changes in the
emission of light signals upon target binding. The field is now a multidisciplinary area of research
that bridges the principles of basic sciences (physics, chemistry, and biology) with fundamentals
of micro/nanotechnology, electronics, and applicatory medicine [7], [8]. Figure 2.2 shows the
timeline for biosensors development until 2010.

Figure 2.2. History and evolution of biosensors over time. Reproduced from [7].
2.3.

Aptamers as Biorecognition Elements

Derived from the Latin word aptus meaning “to fit”, aptamers are often used as one of the most
trending biorecognition elements. First reported in 1990, aptamers recognize specific ligands and
bind to various target molecules from small ions to large proteins with high affinity and specificity
[9]. Aptamers are single-stranded oligonucleotides designed through a combinatorial selection
process called Systematic Evolution of Ligands by Exponential Enrichment (SELEX). As shown
in Figure 2.3, SELEX is an iterative process to search a library of randomly generated
oligonucleotide sequences (1015 – 1018) for strong binding affinities between the target analyte and
oligonucleotide sequences, ensuring a selective and strong interaction pair. The cycle starts with
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incubation of the target bioanalyte with an oligonucleotide library containing all potential aptamer
sequences. Unbound aptamer sequences are washed away, and the bound aptamers are collected
and go through polymerase chain reaction (PCR) amplification to regenerate the oligonucleotide
library for the next SELEX round [3].

Figure 2.3. Schematic illustration of aptamer production by Systematic Evolution of Ligands by
Exponential Enrichment (SELEX) process. Reproduced from [3].
Typically, around 30 – 100 nucleotides long

aptamers possess high chemical stability, mass-

producibility and reusability, longer shelf life, low production cost, small size and no batch-tobatch variations making them superior to their counterparts like antibodies, enzymes, proteins, etc.
Moreover, aptamers undergo conformation change when they specifically interact with their
targets, thus omitting the need for additional labeling process during monitoring of target binding
events [10]. Due to these advantages, aptamers are often used as an integral part of biosensors
leading to the creation of new research field called aptasensors. Due to their versatile potential
applicability, aptamers are used for all our biosensors designed in this work.
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2.4.

Sensing of Protein Biomarkers

A biomarker is a biological characteristic that is objectively measured and evaluated as indicators
of normal biological processes, pathogenic processes or pharmacological responses to a
therapeutic intervention [11]. They can be used to determine disease onset, manifestation,
progression, efficacy of drug treatment, and patient’s susceptibility to develop a certain type of
disease [12]. Among all biomarkers, proteins represent the most studied molecules because of (1)
their direct association with the disease state [13] as well as (2) the availability of a large range of
analytical instrumentation to identify and quantify proteins in complex biological samples, such
as blood, saliva, etc. [14]. It is also possible to generate aptamers for almost every protein target,
which make protein biomarkers a convenient target for aptamer-based biosensors. The high
structural complexity of proteins allows them to bind with aptamer binding by stacking
interactions, shape complementarity, electrostatic interactions, and hydrogen bonding. Moreover,
in principle, proteins can present more than one binding site for aptamers, allowing the selection
of a pair of aptamers binding to different regions of the target and enabling sandwich-assay based
biosensors [15]. Hundreds of protein biomarkers have already been discovered for different
diseases such as, cancer, Alzheimer’s, AIDS, rheumatoid arthritis, malaria, tuberculosis, leprosy,
sarcoidosis, Crohn’s and cardiovascular diseases so far and researches are being done to discover
more protein biomarkers, which is one of the goal of the research field proteomics.

2.5.

Classification of Biosensors

As mentioned earlier, biosensors can be classified into different types depending on the detection
principles they use. Figure 2.4 illustrates the four main types that will be discussed in this section.
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Figure 2.4. Schematic illustration showing the types of biosensors based on different detection
principles.
2.5.1. Optical biosensor
Optical detection is one of the most commonly used popular detection principles because it offers
multiple advantages, such as direct, real-time, and highly sensitive detection of many biological
and chemical substances. Optical detection works by exploiting the interaction of the optical field
with a biorecognition element to produce an electrical signal which is proportional to the
concentration of the analyte. The signal can be either absorbance, fluorescence,
chemiluminescence, colorimetry, interferometry, or surface plasmon resonance.

Among different optical detection mechanisms, fluorescence-based detection is by far the most
widely used sensing technique. Fluorescence-based techniques work on the basis of the Förster
resonance energy transfer (FRET) which involves the coupling of a fluorescent molecule that emits
visible light (fluorophore) to another fluorescent molecule that absorbs visible light and emits at
invisible wavelengths (quencher). Figure 2.5 shows the mechanism for FRET-based optical
biosensor used by Weng and Neethirajan who utilized quantum dots-aptamer–GO complexes
(QDs-aptamer-GO) as probes for sensitive detection of food allergens [16]. This device utilized
quantum dots-aptamer–GO complexes (QDs-aptamer-GO) as probes that undergo conformational
12

change upon interaction with the food allergens. In the absence of the target analyte, the
fluorescence of the QDs is quenched via FRET process between the QDs-aptamer probes and GO
due to their self-assembly through specific π-π stacking interaction, resulting in no fluorescence
signal. Upon binding with the target analyte, due to conformational change of the aptamers, QDsaptamer probes are released from the GO leading to the recovery of fluorescence of QDs.

Figure 2.5. Schematic diagram showing the FRET-based sensing mechanism. Reprinted from
[16].

Though optical biosensors exhibit high sensitivity, often they require labels such as methylene
blue, fluorophore, etc. requiring complex chemistry for attaching the labels to the recognition
elements. Also, optical biosensors are bulky, and require sophisticated laboratory setup along with
trained technicians, thus increasing the overall cost of the sensor setup.

2.5.2. Electrochemical biosensor
Electrochemical biosensors provide an attractive means to analyze the content of a biological
sample due to the conversion of a biological event to an electrical signal. For example, the reaction
under investigation generates a measurable current (amperometric/voltammetric), a measurable
potential or charge accumulation (potentiometric), or alters the electrical conductivity between
electrodes. Electrochemical impedance spectroscopy (EIS), or impedimetric sensing, is also a
commonly used technique where a biological or chemical event causes a change in the impedance
(both resistance and reactance) at the liquid-electrode interface [17].
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(B)

(A)

Figure 2.6. Electrochemical biosensor: (A) target-induced conformation change of aptamer; and
(B) voltammogram as the sensor responds to 64 nM thrombin in 50% blood serum. Adapted from
[18].
Amperometric detection is the first electrochemical technique adopted in microscale [19].
Amperometric biosensors are those devices that transduce the biological recognition events caused
by the oxidation or reduction of an electroactive biological species at the sensing surface into an
electrical signal for the quantification of an analyte within a sample matrix. The intrinsic simplicity
of the transducer lends itself to low-cost portable devices for applications ranging from disease
diagnosis to environmental monitoring [20]. On the other hand, a voltammetric sensing is a
technique where the electrical potential at the working electrode is scanned from one preset value
to another, and the cell current is recorded as a function of the applied potential [21]. One of the
pioneers of electrochemical biosensor is Professor Kevin Plaxco from the University of California,
Santa Barbara (UCSB) who exploited the target-induced conformation change of aptamers to
develop an aptasensor for sensitive detection of thrombin [18] as schematically illustrated in Figure
2.6.

Unlike amperometric technique, this voltametric technique monitors the redox activity across a
range of applied potentials manifesting well-defined current peaks [22]. Voltammetry has been
practiced for a long time and has revolutionized analytical chemistry. The main advantages of
using voltametric methods over spectroscopy or chromatography include their high sensitivity,
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precision, accuracy and cost effectiveness. In the past, voltametric techniques were difficult to
apply without computer controlled potential scan and were not nearly as useful as they are today.
However, in present days, these techniques are largely available due to the advent of computers
and their key role in the control and measurement of the potentials and currents of potentiostats
[21].

Another popular electrochemical detection mechanism is the label-free impedimetric technique
which works by measuring the impedance of the electrode/electrolyte interface over a wide range
of frequencies. The resulting spectrum is called the electrochemical impedance spectrum (EIS)
that can be used to monitor the changes in the electrical properties of the biosensor at different
stages, including different fabrication steps as well as the detection of target recognition events. It
offers several unique advantages that include the ease of signal quantification, the ability to
separate the surface binding events from the solution impedance, non-invasive measurement, realtime monitoring, and label-free detection, making it an effective tool for electrochemical
interrogation [23]. EIS can analyze both the resistive and capacitive properties of the electrode
surface upon excitation/perturbation of the system at equilibrium by a small amplitude sinusoidal
excitation signal [24]. One of the common representation of the EIS is the Nyquist plot (Figure
2.7A), that can be modeled by the Randles circuit as seen in Figure 2.7B. It consists of a solution
resistance (RS), a double-layer capacitance (Cdl), a charge transfer resistance (Rct), and the Warburg
impedance (ZW). RS is inserted as a series element because all the current passes through the
uncompensated solution, while the parallel elements are introduced because the total current
through the electrode is the sum of distinct contribution from the Faradic process and the doublelayer capacitance charging.

Figure 2.7. The Nyquist plot (A); and the corresponding Randles circuit (B).
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Cdl and Rct are often used as the detection parameters in biosensing as they represent the dielectric
and insulating features at the electrode/electrolyte interface, while RS and ZW depend on the bulk
properties of the electrolyte and the diffusion of the redox probe, respectively [25]. For example,
Chen et al. employed the change of Rct to implement a label-free impedimetric biosensor for highly
sensitive detection of lysozyme protein [26]. Lysozyme binding aptamer was modified on a gold

Figure 2.8. Label-free impedimetric biosensors based on electrochemical impedance spectroscopy:
(A) working principle; and (B) EIS measurements for different concentrations of lysozyme.
electrode and EIS measurements were performed in [Fe (CN)6]4−/3−redox couple. As seen in Figure
2.8A, binding of lysozyme to aptamer blocks the path for charge transfer from the redox couple to
the electrode, effectively increasing the charge transfer resistance Rct which is reflected in Figure
2.8B. Due to the huge promise EIS offers, we have designed and implemented an impedimetric
biosensor for selective detection of lysozyme protein that is presented in Chapter 3.
2.5.3. Field-effect transistor biosensor
Field-effect transistors (FETs) have attracted much attention in the biosensing community as they
offer many advantages such as ease of miniaturization, low-cost, large-scale integration capability
with the existing manufacturing process as well as label-free, rapid, and highly sensitive detection
of analytes [27]. A typical FET biosensor is composed of a semiconducting channel that connects
the source and the drain electrodes. Upon adsorption of the biomolecules on the channel surface,
a change in the electric field occurs which affects the gate potential of the device resulting in a
change in the charge carrier density within the channel of the FET. Such change in the drain current
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can be conveniently measured and be utilized as an interrogation strategy to probe the adsorbed
biomolecules.

This type of sensing mechanism has been demonstrated in the past for detecting target analytes in
various media including gases, aqueous liquid, as well as in human serum [27]–[32]. For example,

Figure 2.9. Schematic representation of the working principle of FET biosensor: (A) Device
structure of the electrolyte-gated graphene FET biosensor. (B) Time course of ID for the biosensor.
At 10-min intervals, various concentrations of IgE were injected. Reproduced from [32].

Ohno et al. demonstrated a label-free immunosensing of IgE protein using an aptamer-modified
graphene FETs (Figure 12A) [32]. The aptamer-modified graphene FETs showed selective
electrical detection of IgE protein. From the dependence of the drain current variation on the IgE
concentration, they also estimated the dissociation to be 47 nM, indicating good affinity (Figure
2.9).

2.5.4. Mass sensitive biosensor
Gravimetric or mass sensitive biosensors work on the basic principle of measuring the change in
the mass at the sensing surface caused by the binding of the analyte to the receptors. Most mass
sensitive biosensors use piezoelectric quartz crystals which can be either in the form of resonating
crystals (such as quartz crystal microbalance, QCM) or surface acoustic wave (SAW) devices [33].
The QCM biosensors have been very popular in the area of rapid detection of pathogens [34] and
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toxins [35] because of their multifarious advantages such as ease of use, shorter analysis time, lowcost, as well as the possibility of label-free and real-time detection. On the other hand, SAW-based
biosensors can detect acoustic waves generated by the interdigital transducers (IDTs) which are
periodic metallic bars deposited on a piezoelectric material. Upon recognition of an analyte by the
immobilized receptors, the velocity of the SAW changes that produces signal by the driving
electronics. Figure 2.10 shows the operating principle of a QCM-based mass sensitive biosensor

Figure 2.10. Operating principle of a QCM-based mass sensitive biosensor. When any analyte
binds to the selective receptor, a change in the mass loading occurs that can be detected by a change
in the frequency. Reproduced from [36].
for virus recognition. The change in mass in response to virus binding with the selective receptor
is detected as a change in frequency of QCM transducer.

2.6.

Summary

The following table (Table 2.1) summarizes the advantages and disadvantages of the four
detection techniques described above.

Table 2.1. Advantages and disadvantages of different detection techniques [33].
Types of biosensor

Advantages

Disadvantages
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Optical

High sensitivity, remote controllable

Often requires labels, costly,
fragile, and bulky setup

Electrochemical

FET based

Mass sensitive

Good resolution, excellent accuracy,

Susceptible to temperature

repeatability

changing, short shelf-life

Highly sensitive, faster response,

Not suitable for receptors longer

mass producible, label-free

than the Debye length

Highly sensitive, suitable for target

Fragile and mechanically unstable

molecules that don’t have
electrically conducting property or
optical signal (e.g. virus)

In this thesis, we developed two types of biosensors, namely the impedimetric and the GFETbased, for selective detection of protein biomarkers.

2.7.

Conclusion

In this chapter, I describe the basics of biosensors—definition, working principle, history, and
evolution. A brief introduction of aptamers as recognition elements and proteins as target
biomarkers is also presented. In addition, I present different types of biosensors, namely optical
biosensor, electrochemical biosensor, field-effect transistor biosensor, and mass sensitive
biosensor. In particular, their working principle, state-of-the-art development as well as the
challenges are delineated. Finally, their comparative advantages and disadvantages are
summarized in table.
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CARBON-BASED NANOTECHNOLOGY
FOR BIOSENSING
3.1.

Introduction

Modern technology is characterized by its emphasis on miniaturization, a trend to manufacture
ever smaller mechanical, optical and electronic products and devices. For example, in the IC
industry, remarkable technological progress has occurred in terms of reductions in the size of
transistors, thus increasing the number of transistors per chip. This trend, which is known as the
Moore’s law (Figure 3.1), states that the number of transistors in an IC doubles about every two
years [37]. This trend of miniaturization has evolved in time and taken us to the nanometric regime,
leading to the term “nanoelectronics”. Essentially, nanoelectronics is the application of

Figure 3.1. The number of transistors in the CPU as a function of time. The trend shows a doubling
approximately every two years which is known as the Moore’s law. Reproduced from [37].
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nanotechnology1 for electronic components and aims at improving the capabilities of electronics
such as display, size, and power consumption of the device for everyday use [38]. It is based on
the quantum mechanical properties of the hybrid material, semiconductor, one dimensional (1D)
materials such as nanotubes, 2D materials such as graphene, and so forth. The integration of
nanoelectronics and nanoelectronic devices with biosensors leading to the term nanobiosensors
has become very popular due to different advantages it offers to the sensor. These advantages are
achieved by using different nanomaterials as the biosensing interface and nanodevices as the
transducers.

.
Figure 3.2. Nanoscale showing the dimension range for nanomaterials. Reproduced from [39].
Nanomaterials are materials with minimum one dimension in the nanoscale (Figure 3.2). In this
scale, nanomaterials possess unique properties that play significant role in the development of

1 According to

the National Nanotechnology Initiative (NNI), nanotechnology is the understanding

and control of matter at dimensions between approximately 1 and 100 nm, where unique
phenomena enable novel applications.
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biosensors. This significance arises from the fact that nanomaterials can help address some key
issues in designing biosensors. Such issues include: (1) design of the biosensing interface so that
the analyte selectively interacts with the biosensing surface; (2) achievement of efficient
transduction of the biorecognition event; (3) increase in the sensitivity and selectivity of the
biosensors; and (4) improvement of response times in highly sensitive systems [40]. More
specifically, nanomaterials make biosensors compatible with biological matrices so that they can
be used in complex biological samples or even in vivo; enable fabrication of viable biosensors that
operate within confined environments such as inside cells; and simultaneous detection of multiple
biosensors in one device. Nanomaterials can be classified as zero-, one-, and two -dimensional
systems. This includes semiconductor quantum dots, metallic nanoparticles, metallic or
semiconductor nanowires or nanotubes, nanostructured conductive polymers or nanocomposites,
mesoporous materials, etc. Among them carbon-based nanostructures are the most popular because
of their low-cost, wide-availability, potential biocompatibility, etc.
The electronic configuration of carbon in ground state is 1s22s22p2. But in excited state, carbon
can exist in three different states corresponding to sp3-, sp2-, and sp- hybridization of their valence
orbitals leading to the formation of different carbon allotropes. These allotropes enable the
formation of different types of carbon nanomaterials such as CNTs, graphene, carbon dots, carbon
nanofibers, nanodiamonds, and buckminsterfullerene as seen in Figure 3.3. The following section
will discuss the fundamentals of carbon nanoelectronics with respect to carbon nanotubes and
graphene.

Figure 3.3. Various forms of carbon nanostructures. Reproduced from [41].
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3.2.

Carbon Nanoelectronics

The field of carbon nanoelectronics has grown significantly with rapid developments in device
performances and high yield assembly of single-walled carbon nanotubes (SWCNT) and
graphene-based devices. Such a rapid growth is largely fueled by the unique single-atomic layer
honey-comb structure of these carbon allotropes, that leads to many extraordinary physical
properties such as extremely high electron and hole mobilities (potentially in excess of 100,000
cm2/V/s), extremely high strength (greater than steel), along with other extreme properties [42],
[43]. In this section, the electronics of these carbon nanomaterials, CNTs and graphene in
particular, will be discussed.

3.2.1. Carbon nanotubes (CNTs)
To date, arguably the most widely studied one-dimensional (1D) material in nanoelectronics is the
carbon nanotube. CNTs are well-ordered, graphitic sheet rolled up into a hollow cylinder of sp2hybridized carbon atoms [40]. They can be classified into two categories – single-walled carbon
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs). Though SWCNTs and
MWCNTs are similar in certain aspects, they have some striking differences. Structurally,
SWCNTs are single sheets of graphene rolled into cylinders, MWCNTs are composed of several
concentric tubes (approx. 6 – 25) that share the same longitudinal axis. As 1D carbon allotropes,
CNTs have lengths that can range from several hundred nanometers to several millimeters, but
their diameter depends on their types: for MWCNTs, the outer diameter is typically 30 – 50 nm
and for SWCNTs, it is typically 0.7 – 2.0 nm [44].

Among different electronic properties, the conductivity of the CNTs is especially critical for their
role as nanomaterials in electrochemistry. While MWCNTs are regarded as metallic—a highly
attractive property for an electrode, the electronic properties of SWCNTs are controlled by the
chiral vector, that connects the centers of two hexagons. The chiral vector is given by 𝐶 = 𝑛𝑎1 +
𝑚𝑎2 (Figure 3.4), where 𝑎1 and 𝑎2 are the unit vectors of the graphene lattice, and the pair of
integers (n, m) is called the chiral index or just chirality. Depending on the chirality, SWCNTs can
be either metallic if (n-m) is multiple of 3; or semiconducting otherwise [40]. Thus, with small
diameter SWCNTs approximately two-thirds are semiconducting, and one-third are metallic.
However, as the diameter of the tubes increases, the bad gap tends to zero resulting in zero band24

gap semiconductor. Therefore, the varieties of conductivities in a mixture of SWCNTs can
complicate their applications in electrochemistry compared to MWCNTs.

Figure 3.4. Chirality in SWCNTs. A chiral vector C can be defined by a chiral index (n, m) using
the basis vectors a1 and a2 of a graphene sheet. Reproduced from [45].

CNTs can be produced by different methods such as chemical vapor deposition (CVD), laser
ablation and arc discharge [46]. The resulting product not only contains the CNTs, but also
contains the catalyst particles and amorphous carbons as impurities. In addition, the CNTs are not
identical in length and chirality. This is one reason why the large-scale manufacturing of identical
CNT devices still remains a challenge [47].

Electrochemically, CNTs are not very reactive due to their highly graphitized nature. But there is
evidence that favorable electrochemical properties of SWCNTs can be achieved from oxygenated
carbon species, especially carboxyl moieties that are produced on the tips of the nanotubes during
acid purification [48], [49]. This is in contrast to the MWCNTs that experience slow rate of
heterogeneous electron transfer if functionalized with oxygen-containing groups [50], [51].
According to Pumera et al., the oxygen-containing groups in fact play a minor role in the
heterogeneous electron transfer for electrochemically activated MWCNTs [52]. Rather, they
suggest that the increased heterogeneous electron transfer is due to an increase of the density of
edge-like sites on the sidewalls of the tubes.
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The electrochemical behavior of CNTs was explored by several groups to design and implement
aptamer-based biosensors [53], [54]. For example, Rohrbach et al. have implemented a label-free
impedimetric aptasensor for selective detection of lysozyme using MWCNTs [54]. The working
electrode was modified with MWCNTs which was deposited by simple pipetting of carboxylated
(5%) MWCNT suspension. In the following step, aminated anti-lysozyme aptamers were
immobilized on the working electrode via the covalent linkage between the carboxylic groups of
the nanotubes and the amino groups of the aptamers (Figure 3.5A). When any lysozyme binding
occurs, the net positive charge of the aptamer-lysozyme interaction enhances the charge transfer
from the redox couple to the working electrode, thereby decreasing the charge-transfer resistance,
Rct (Figure 3.5B). By monitoring the change in Rct, they were able to detect lysozyme with a
detection limit of 862 nM.

Figure 3.5. Impedimetric biosensor for label-free detection of lysozyme using MWCNTs: (A)
modification of the working electrode with MWCNTs; and (B) electrochemical impedance
spectroscopy measurements for different concentrations of lysozyme and the corresponding
calibration curve. Reproduced from [54].

The sidewalls of the nanotubes being very hydrophobic, dispersion and manipulation of CNTs in
common solvents for controlled modification of electrode surface presents a major challenge.
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Moreover, their tendency to aggregate and form clusters owing to high van-der-Waals force
between the tubes limit their dispersibility in aqueous or polar solvents [48], [55]. As a
consequence, dispersing tubes is usually performed in non-polar organic solvents such as dimethyl
formamide (DMF), N-Methyl-2-pyrrolidone (NMP), tetrahydrofuran (THF) or with the aid of
surfactants, polymers such as nucleic acids or oxygenated functional groups such as carboxylic
acids [48], [53], [56]. Figure 3.6 illustrates the nucleic acid-assisted dispersion of CNTs where
single-stranded DNA (ssDNA) helically wraps the CNT using the π – π stacking internactions
between the nucleotide base of the ssDNA and the CNT sidewall, thus converting it into a watersoluble object [57]. Several research groups have used this nucleic acid-assisted dispersion of
CNTs to implement nucleic acid aptamer-based biosensors [58], [59]. For example, Lian et al. has
developed a piezoelectric aptamer biosensor on interdigital electrode (IDE) for selective detection
of lysozyme protein [59]. The IDE was modified with aptamer-wrapped-SWCNTs which was
connected to the oscillator circuit in series with the piezoelectric quartz crystal (SPQC). In the
presence of target lysozyme, the SWCNTs, being substituted by the lysozyme with greater affinity
towards the aptamer than the SWCNTs, came off from the IDE surface causing a frequency change
of the SPQC-IDE.

Figure 3.6. Nucleic acid-assisted dispersion of CNT where DNA wraps the CNT helically making
it water-soluble. Reproduced from [57].
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There are several deposition methods of carbon nanotubes experimented by many groups, such as
the dip coating [60], spray coating [61]–[63], electrophoretic deposition [64], printing [65]–[68]
and others. Among them, printing is one of the prominent methods of interest today. Specially,
inkjet-printing offers several unique advantages such as low cost, rapid printing, easy formation
of microarrays, automation, easy patterning control and mass-producibility [56]. Inkjet-printing is
currently being used to deposit various types of conductive nanomaterials such as gold and silver.
Although these metals are excellent conductors, carbon nanotube-based inks are becoming very
popular because of their lower cost and more versatile properties in the sense that they can behave
both as a semiconductor and a conductor. In this thesis, the possibility of employing inkjet-printing
of CNTs was explored for implementing electrochemical detection of protein biomarkers.
Aptamers are used as the receptors that simultaneous act as one the dispersing agents for the CNTs
for preparing the ink for the ink-jet printer.

3.2.2. Graphene
Known as the world’s first 2D material, graphene has revolutionized the field of biosensing due to
its many advantages that make it compatible with biosensing platforms. It was first isolated and
characterized in 2004 by two researchers: Andre Geim and Kostia Novoselov of the University of
Manchester, bringing them the Nobel prize in physics in 2010 [69]. With a thickness of single
atomic layer, graphene is isolated from graphite that can be considered as a stacked pile of multiple
graphene layers held together by van-der-Waals forces. It is the thinnest known material with a
thickness of 0.35 nm and is composed of 𝑠𝑝2 -bonded carbon atoms arranged in hexagonal network
[70]. Though incredibly flexible, it is the strongest ever measured material that demonstrates
excellent conductivity to electricity (better conductivity than copper) and shows unique
morphological properties.

Graphene can be produced by different methods such as mechanical exfoliation, chemical vapor
deposition (CVD), etc. The first demonstrated process used by Geim and Novoselov to derive
graphene was exfoliation of graphite by using a simple scotch tape technique [71]. While
mechanical exfoliation is a reliable method for producing high quality defect free graphene, it
produces only a few micrometer-sized sheet and the process being time consuming, not suitable
for large scale production. By contrast, chemical vapor deposition is a cost and time effective
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method of producing high quality graphene in large scale. A typical CVD process for graphene is
performed under vacuum and uses heated substrate to break apart the atoms in a gaseous
hydrocarbon such as methane. The remaining carbon atoms then align themselves atop the
substrate in the distinctive hexagonal structure of graphene. The graphene film can then be
transferred to the desired substrate through various techniques. A disadvantage of the CVD process
is that the growth and transfer process can produce defects in the graphene lattice. Perfecting the
CVD process is an ongoing goal and is necessary for the commercialization of the many useful
applications of graphene.

In the past decades, graphene has been experiencing unparalleled usage in the material world and
has recently gained significant attention in the field of electrochemical and FET sensors thanks to
its ability to be integrated with different nanomaterials, such as metals, metal oxides, and quantum
dots [72], [73]. The biocompatibility of graphene in biosensing generates from the combination of
its versatile properties, such as, enhanced specific surface area, electrical conductivity, chemical
stability, ease of manipulation, integration-capabilities with different nanomaterials, high
sensitivity to biomolecules as well as good adsorption capability [70]. The theoretical specific
surface area of graphene is 2630 m2/g [74] which is approximately twice the specific surface area
of CNT that ranges from 50 – 1315 m2/g [75]. With such excellent physical properties, graphene
can even achieve the detection of single molecule making it a promising candidate for biosensing.
Another property that makes graphene suitable for biosensing is its ease of functionalization.
Graphene surface can easily be modified with a variety of chemical groups or biomolecules, thanks
to its hydrophobicity in nature and the tendency to form agglomerates in most of the solvents due
to van-der-Waals forces [70].
Many of the graphene’s excellent electronic properties originate from its unique band structure
that exhibits the degeneration of the valence and conduction band at the Dirac point.
The degeneration at the Dirac point indicates that graphene has a zero bandgap that can be
modulated by physical or chemical surface modifications. Also in the hexagonal honeycomb
lattice, each carbon atom with its three 𝑠𝑝2 -hybridized planar orbitals forms a strong sigma bond
(Figure 3.7) with three neighboring carbon atoms resulting in a strong graphene structure that
offers the longest ‘mean free path’ on the order of several microns among any known nanomaterial
29

[70], [76]. On the other hand, the delocalized electrons in the π bonds above and below the basal
plane contributes to the high electrical conductivities and mobilities: the room-temperature
mobility has been measured at 15,000 cm2V-1s-1 while a clean, suspended single layer graphene
has achieved 230,000 cm2V-1s-1 at temperatures near absolute zero. This high carrier mobility
makes graphene a suitable candidate for biosensing with excellent sensitivity as even a single
biomolecule that comes into contact with its surface can module these properties either by n- or ptype doping, surface charge induced gating or by Shottkey-barrier modification [40], [70].

As a transducer material, graphene has been investigated by many research groups. For example,
Lu et al. have implemented a sensing platform for selective detection of DNA and proteins using
graphene oxide [77]. Chang et al. have developed a graphene-based fluorescence resonance energy
transfer (FRET) biosensor for sensitive detection of thrombin with a detection limit as low as 31.3
pM which is two orders of magnitude lower than CNT based fluorescence sensors [78]. Others
have incorporated graphene into a field-effect transistors (FETs) for detection of various target
analytes including antigens, antibodies, and charged molecules [32], [79]–[83].
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Figure 3.7. Electronic properties of graphene: (A) lattice structure; (B) sp2 hybridization; (C) 3D
band structure; and (D) the approximation of the low-energy band-structure as two cones touching
at a single point called Dirac point (bottom). Adapted from [70].

3.2.2.1.

Graphene FET (GFET) as an emerging nanoelectronic device

A field-effect transistor (FET) is an electronic device which is capable of modulating the current
through a semiconducting channel by the application of an electric field. In a GFET, graphene is
used as the semiconducting channel between two metal electrodes: source and the drain that lie
atop an electrical insulator such as SiO2 (Figure 3.8A). Whenever any charged molecule comes in
contact with the graphene film, it causes a measurable change in the channel conductance leading
to a change in the drain-source current, which can be used as a readout signal for the sensing
mechanism.
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Figure 3.8. Schematic illustration of the (A) device structure of a graphene filed-effect transistor
(back-gated); and (B) ambipolar transfer characteristics of the GFET device showing regions for
hole and electron conduction.
Due to zero-bandgap structure of graphene, carriers (electrons and holes) can be converted to each
other at the Dirac point resulting in the formation of ambipolar transfer characteristics as shown in
Figure 3.8B. In the absence of any doping, the gate voltage at the minimum current is the charge
neutrality point, VCNP, usually referred to as the Dirac voltage, VDirac., which corresponds to having
the Fermi level at the Dirac point (Intrinsic Fermi level). For VGS> VDirac the Fermi level is in the
conduction band and the channel current is due to the electron conduction, while for VGS< VDirac
the Fermi level is in the valence band and the channel current is due to the hole conduction. With
VGS near VDirac, there are a few of either type of carriers and the conductivity of graphene is
minimum. However, the non-zero current here is due to the thermal distribution of carriers as well
as spatial fluctuations in energy of the Dirac point [84]. Any adsorbed charged molecule on
graphene channel surface can induce a horizontal shift to the Dirac point, which can be used as an
additional sensing mechanism.

3.2.2.2.

Electrolyte-Gated GFET (EGFET)

To apply a GFET to the in-vitro real-time biosensing, the graphene channel must be in exposed to
the sample solution. This can effectively be done by replacing the insulating material covering the
gate electrode with an electrolyte solution leading to the so-called electrolyte-gate GFET (EGFET)
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device [85]. An EGFET is schematically illustrated in Figure 3.9A. There are several advantages
of EGFETs compared to conventional GFETs discussed above. The advantages are listed below
[85]–[87]:
•

Low operating potential (<1V) preventing undesired redox reaction or even water splitting
enabling sensing of biomolecules in aqueous environment.

•

Very stable performance and high transconductance.

•

Low noise operation.

•

Enables real-time measurement.

In an EGFET, the semiconductor channel and the gate electrode are in direct contact with the
electrolyte, forming two electrical double layer (EDL) capacitors (CG1 and CG2) in series (Figure
3.9B), equivalently known as the geometrical capacitance, CG. The total capacitance can be
expressed by the following equation [88]:
1
1
1
=
+
𝐶 𝐶𝐺 𝐶𝑄

Where CQ is the quantum capacitance of graphene is related to the Fermi level shift and hence the
potential drop across this capacitance controls the Fermi level shift. Each of the geometrical
capacitance can be modeled as a parallel plate capacitor with a plate distance d, which is equal to
a new quantity called the Debye length.
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Figure 3.9. Electrolyte-gated graphene field effect transistor: (A) Schematic illustration; and (B)
the electrical double layer capacitors formed at the graphene-solution and gate electrode-solution
interfaces.
To fully describe the graphene FET-based sensing mechanism, two major effects caused by the
presence of charged molecules on the graphene film must be considered; that is the electrostatic
gating effect and the charge transfer doping effect. These two effects impose opposing actions on
the sensing mechanisms. The actual sensing mechanism may be determined by the combination of
these two mechanisms.

The electrostatic gating effect dominates when the concentration of the adsorbed charged molecule
is high so that the inter-molecular distance is less than the Debye length and the adsorbed
molecules behave as one of the two plates of the electric double layer (EDL) formed on the
graphene-electrolyte interface. Now, any additional charged molecule adsorbed on graphene will
modulate this charge density in the EDLs resulting in a change in the channel current as well as
causing a shift in the Dirac point. If the adsorbed biomolecules are positively (or negatively)
charged, the Dirac voltage will shift in the negative (or positive) direction. In other words, if more
positive charges are attached to graphene, the applied voltage must be less positive in order to
compensate for the additional charge [89], [90].
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The charge transfer doping effect is caused by the direct charge transfer (Figure 3.10) from the
adsorbed molecules to graphene channel especially when the adsorbed species are at low
concentration or weekly charged. In this case, the adsorption density is quite small and the distance
between the adsorbed molecules is larger than the Debye length of the channel material and the
charge transfer is dominant between the adsorbed species and the channel material. The Dirac
voltage shift caused by the charge transfer doping effect is in the opposite direction to that caused
by the electrostatic gating effect. For example, if the adsorbed molecules are positively (or
negatively) charged, the Dirac voltage will shift in the positive (or negative) direction [89].

Figure 3.10. Schematic illustration of doping effect in graphene field-effect transistor.
Due to the several advantages EGFETs offer with respect to the biosensing applications, several
groups have implemented this configuration for developing GFET based biosensors for highly
sensitive detection of biomolecules. As an example, Wang et al. successfully used a label-free
EGFET device for immunoglobin E (IgE) biomarker in human serum with a limit of detection in
47 pM [91]. Hao et al. developed another EGFET biosensor for real-time monitoring of insulin
with a limit of detection of 35 pM [79]. They also demonstrated that these GFET biosensors can
find applications in clinical diagnostics for label-free monitoring of insulin and timely prediction
of accurate insulin dosage.
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3.2.2.3.

Debye length

One of the factors that limit the capabilities of GFET biosensors is the Debye length, which is the
maximum distance away from the graphene surface beyond which the GFET device is able to
screen a charge. The Debye screening length of an electrolyte is given by [92]:

𝑑=√

𝜖𝜖0 𝑘𝐵 𝑇
2𝑛𝑍 2 𝑒 2

where 𝑛 is the bulk concertation of ions in the solution, 𝑍 is the charge of the ion and 𝑒 is the
charge of an electron. The Debye length can be approximated as:

0.1

𝑑 ≈ 0.96 √ 𝑐 nm

where c is the molar concentration of the buffer salt solution. For aptamer-based GFET sensors,
the concentration of buffer solution should be such that the Debye length is essentially greater than
the aptamer length.

Another factor that limits the performance of a GFET biosensing device is the Faradic currents
which are created by the reduction or oxidation of the molecules at the liquid-electrode interface.
This causes an unwanted leakage current through the gate electrode. In general, Faradic currents
should be less than 1 nA. One of the ways to reduce Faradic currents is by passivation of the
electrodes with a layer of oxide to reduce the interaction between the electrode surface and the
solution [93].

3.3.

Conclusion

In this chapter, I discuss the theory of carbon-based nanoelectronics. Specially, two popular carbon
nanomaterials, namely CNT and graphene are discussed—their electronic and electrochemical
properties, manufacturing, as well as significance in biosensing. Moreover, I present a brief
literature review on biosensing principles using both nanomaterials.
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INKJET-PRINTED APTAMER-BASED
ELECTROCHEMICAL BIOSENSOR
4.1.

Introduction

Aptamers hold great interest to the scientific community due to their versatile advantages with
regards to biosensing. Their many advantages, including high affinity and binding efficiency to
the target analyte, chemical and thermal stability, resistance to harsh environmental conditions,
long shelf-life, mass producibility at low-cost, and reusability make aptamers attractive
alternatives to their natural counterparts, such as antibodies and enzymes [54], [94]. Selected in
vitro by a well-established technique known as the Systematic Evolution of Ligands by
EXponential enrichment (SELEX), aptamers can be used for the selective detection of a broad
range of analytes including proteins, peptides, amino acids, drugs, metal ions, and even whole cells
[95]. The detection of lysozyme has received much attention among researchers because of its
various significances in medicine, as well as in the food industry. Having a molecular weight of
14.4 kDa with a primary sequence containing 129 amino acids and an isoelectric point of 11.0,
lysozyme is a ubiquitous enzyme widely available in diverse organisms such as bacteria,
bacteriophages, fungi, plants, and mammals [96], [97]. Lysozyme also plays an important role as a
biomarker for diagnosing diseases such as breast cancer [98], Alzheimer’s disease [99], rheumatoid
arthritis [100], malaria [101], AIDS [102], tuberculosis and leprosy [103], sarcoidosis [104], and
Crohn’s disease [105]. Typically, the concentration of lysozyme in a healthy person’s saliva is
13.8 µg/mL [59], whereas the concentration is 0.463–2.958 µg/mL in a healthy person’s serum
[94].

Existing aptamer-based biosensors use different detection schemes such as high-performance
liquid chromatography (HPLC), quartz crystal microbalance (QCM), surface plasmon resonance
(SPR), and fluorescence-based optical detection. However, these methods suffer from several
drawbacks as they are often time-consuming, expensive, operated by highly trained technicians,
and performed in a laboratory setting [54], [106]. However, as an alternative, electrochemical
detection offers the potential for a rapid, low-cost, and sensitive detection of the target species.
Especially, electrochemical impedance spectroscopy (EIS) has proven to be a powerful and
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sensitive tool for investigating the features of surface-modified electrodes [106]. EIS can be used
to monitor the changes in the electrical properties of the biosensor at different stages, including
different fabrication steps as well as the detection of target recognition events [26]. The unique
advantages of EIS include the ease of signal quantification, the ability to separate the surface
binding events from the solution impedance, non-invasive measurement, real-time monitoring, and
label-free detection, making it an effective tool for electrochemical interrogation [26].

An important step towards the fabrication of the aptamer-based electrochemical biosensor is the
immobilization of the aptamer probes onto the working electrode so that the target recognition by
the aptamer can be transduced into a measurable electrical signal. Rohrbach et al. developed a
lysozyme biosensor where the covalent coupling between the carboxylic groups of CNT and the
amino groups linked to the aptamer was used to immobilize the aptamer [54]. An EDC/NHS
coupling-based immobilization technique has been exploited by Kara et al. to develop an aptamerbased biosensor for the detection of thrombin with a detection limit of 105 pM using EIS [53].
Others have used thiol-gold binding [59], [106], [107], biotin-avidin affinity-based binding [108],
and surface adsorption [109] to immobilize aptamers on the respective electrodes. However, such
approaches can be difficult to reproduce, often require complex chemistry, lack control over
aptamer density, and may not be suitable for large-scale manufacturing and mass production.

Herein, we explore the possibility of using the inkjet-printing technique for a reliable and
reproducible aptamer immobilization method. We propose the use of a dispersed CNT-aptamer
complex as a printable ink to be deposited on the electrode. The ink exploits the strong π–π stacking
interaction between the nucleotide bases of the single stranded DNA and the sidewalls of the CNT
[57]. Inkjet-printing is finding applications in areas such as flexible electronics, disposable sensors,
and wearable devices [110]. Particularly, due to its on-demand printability of the devices, inkjetprinted sensors can potentially be used as point-of-care (POC) diagnostic tools and disposable
testing kits. In contrast to other existing aptamer immobilization techniques, the proposed
approach of inkjet-printing offers many advantages, including mass producibility, uniform
deposition of materials, fully automated process, and high throughput [110]–[112]. We also
demonstrate in this work that the aptamer density can be controlled by utilizing the number of
printing layers. After the deposition of the CNT-aptamer ink, the sensor is then used for the
38

detection of lysozyme using EIS. The binding affinity of our aptamer probe to lysozyme was
confirmed by the square wave voltammetric techniques using methylene blue (MB)-labeled
aptamers (see Appendix B).

Figure 4.1 presents the working principle of our proposed biosensor. Figure 4.1A shows the CNTaptamer complex deposited on the working electrode. Due to the negatively charged backbone as
well as the insulating property of the aptamers, the charge (electron) transfer from the redox probe
(e.g., ferro- and ferri-cyanide) to the electrode is hindered, i.e., the charge transfer resistance (Rct)
is large as illustrated by the larger diameter of the Nyquist plot in Figure 4.1B. When the sensor is
exposed to lysozyme as shown in Figure 4.1C, the aptamer unwraps itself from the CNT due to its
preferential binding to the lysozyme. This conformational change in the aptamers opens up the
path for electrons to easily flow from the redox probes to the working electrode, resulting in an
enhancement in the rate of charge transfer and thus a reduction in Rct, as shown in Figure 4.1D
with a smaller radius of the Nyquist curve.

Figure 4.1. Working principle of the aptamer-based biosensor. Initially, the printed sensor blocks
the charge transfer from the redox probe to the electrode due to the negative backbone of DNA
bases (A); and the corresponding Nyquist curve (B). When exposed to the lysozyme, the antilysozyme aptamer unwraps itself from the carbon nanotube (CNT) and binds to the lysozyme,
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opening up the current path for enhanced charge transfer (D); and the corresponding Nyquist curve
(D).

4.2.

Materials and Methods

4.2.1. Materials
Multi-walled carbon nanotubes (>99.9% purity, 30–50 nm outer diameter, 10–20 µm length)
modified with carboxyl functional groups (–COOH) were purchased from Cheap Tubes (VT,
USA)

and

used

without

further

modification.

Single-stranded

anti-lysozyme

DNA

oligonucleotides (sequence designed by Ellington and co-workers [113]) were synthesized by
Sigma-Aldrich. The sequence of the oligonucleotides is: 5′-ATC AGG GCT AAA GAG TGC
AGA GTT ACT TAG-3′. Methylene blue (MB)-labeled and thiolated DNAs with the same
sequence (thiol group attached at the 5′ end MB attached at 3′ end) were purchased from LGC
Biosearch Technologies (CA, USA). Lysozyme from chicken egg white, bovine serum albumin,
and thrombin were also purchased as lyophilites from Sigma-Aldrich. The stock solutions were
prepared by dissolving the lyophilites in fresh ultrapure triple-distilled water and stored at −20 °C
until used. The diluted solutions of proteins were prepared in 50 mM phosphate buffer solution
(PBS, pH 7.4, Sigma-Aldrich).
4.2.2. Electrochemical Assay
The Bio-Logic VSP-300 potentiostat was used for the electrochemical measurements. All
experiments were performed using screen-printed carbon electrodes (SPCEs) purchased from
DropSens (Spain). These disposable SPCEs consist of three electrodes: a carbon working electrode
(WE), a carbon counter electrode (CE) and a silver pseudo reference electrode (RE). The WE is
circular in geometry with a diameter of 4 mm.

4.2.3. Ink Preparation
First, 0.25 mg/mL of multi-walled carbon nanotubes (MWCNTs) were mixed with 5 µM lysozyme
binding aptamer in 30% N-methyl pyrrolidone (NMP) solution. Next, the mixture was sonicated
using an ultrasonic bath sonicator for 2 h and then centrifuged at 6000 rpm for 30 min in order to
remove any MWCNT aggregates. Afterwards, the supernatant was collected and loaded into the
ink cartridge for printing. The unused ink was stored in a refrigerator at 4 °C.
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4.2.4. Inkjet-Printing
The Fujifilm Dimatix Materials Printer (DMP-2831) was used for the inkjet-printing. It uses a 16jet Dimatix Materials Cartridge with 10 pL drop volumes. The minimum patterning resolution of
this printer was reported to be 20 µm according to the product specification sheet. Each device
was printed with 5 layers of the CNT-aptamer ink. The ink was printed at a voltage of 40 V, a
nozzle temperature of 35 °C and a 5 kHz jetting frequency. The amount of ink printed per layer is
estimated to be approximately 315 nL (see Appendix A for detailed calculation).

4.2.5. Removal of the Unbound Aptamers
After the printing process, the SPCE devices were dried on a hotplate at 35 °C and gently washed
with deionized (DI) water to remove any unbound DNAs. The effect of washing is presented in
Figure 4.2.

Figure 4.2. The effect of washing on the printed sensor. After the first wash, the Rct value obtained
from the Nyquist curve drops by approximately 31%. Subsequent washes do not significantly
change the radius of the Nyquist curves, suggesting that the remaining aptamers are securely
attached to the CNTs.

It can be seen that the radius of the Nyquist curve corresponding to the first wash drops
significantly and remains stable for the subsequent washes. This indicates that the majority of the
unbound or loosely bound aptamers have been removed after the first rinsing procedure during
which 31% reduction in the charge transfer resistance has been observed.
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4.2.6. EIS Measurements
The electrochemical impedance spectroscopy (EIS) measurements were performed with 1 mM
K4[Fe(CN)6]/K3[Fe(CN)6] (1:1) mixture (pH: 7.25) as a redox probe prepared in 10 mM PBS. The
impedance was measured in a frequency range from 100 kHz to 100 mHz with a DC potential of
0.115 V versus Ag pseudo reference with a sinusoidal AC voltage of 5 mV RMS. The sampling
rate was 10 points per decade. The charge transfer resistance (Rct) of the equivalent circuit was
obtained by fitting the measured Nyquist curve using a modified Randles circuit.

First, the EIS measurement was taken on a CNT-aptamer ink-printed SPCE by placing a 50 µL
droplet of the ferro-/ferri-cyanide solution on the surface of the electrode for obtaining the baseline
measurement (this will be called pre-lysozyme measurement). Next, the same device was exposed
to a 50 µL droplet of lysozyme of varying concentrations (0, 0.25, 0.50, 1, 2, 5, 10, and 20 µg/mL)
and incubated for 15 min. The electrode was then rinsed with 50mM PBS buffer followed by
rinsing in DI water to remove any unbound lysozyme protein. Afterwards, a second EIS
measurement was performed to obtain the response of lysozyme binding with the aptamers (this
will be called post-lysozyme measurement).

After making two rounds of EIS measurements on the same device, one for the pre-lysozyme
condition and one for the post-lysozyme condition, the Rct values were obtained by curve-fitting
the Nyquist plot to the modified Randles circuit model. The relative change of the transduction
signal (∆R ct ) can be calculated in percentage as follows:
∆R ct (%) =

Rct,post −Rct,pre
Rct,pre

× 100%

(1)

where Rct,pre and Rct,post denote the charge transfer resistances of the pre-lysozyme and postlysozyme measurements, respectively.

4.2.7. Chronocoulometric Experiments
To calculate the packing density of aptamers on the WE, chronocoulometry (CC) was performed
by applying a pulsed voltage with a pulse width of 200 mV versus Ag pseudo reference and a pulse
period of 10 s. First, the measurement was done with the sensor in 10 mM Tris-HCl buffer. Next,
the sensor was incubated in 1 mM hexamine ruthenium (III) chloride (RuHex) in 10 mM Tris-HCl
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for 1 h. Then, the sensor was washed in DI water to remove any excess RuHex that was not bound
to the DNA aptamer. Finally, the CC was performed for the RuHex incubated sensor. Following
the experiment, the aptamer packing density was calculated from the CC intercepts at t = 0. See
Appendix C for the experimental details.

4.3.

Results and Discussion

4.3.1. Patternability of the CNT-Aptamer Ink
The patternability of the aptamers has been characterized optically by fluorescence imaging. For
the ink preparation, the aptamers were labeled with a fluorescence (6-FAM) modified at the 5′ end.
Different numbers of layers (one to eight) were printed on a microporous PET transparency film
as a single droplet array, as shown in Figure 4.3A. The droplet array was washed with DI water
before imaging to remove loosely adsorbed aptamers that remained from the ink. The intensity
profile of the array is presented in Figure 4.3B against the number of printed payers. It can be seen
that, for the number of print layers from one to six, the fluorescence intensity is proportional to the
number of layers. However, for seven and eight layers of printing, the intensity decreases slightly.
This decrease in intensity for higher number of layers can be attributed to the possible quenching
of the fluorophore due to the overcrowding of the aptamers that can lead to the cross-hybridization
among neighboring aptamers, a potential result of the self-complimentary nature of the individual
aptamer sequences [114]. Furthermore, the coffee ring effect [115] becomes more pronounced for
higher number of layers, as can be seen in Figure 4.3A. In summary, we have demonstrated the
ability to control the density of the immobilized aptamer by choosing the proper number of printed
layers. Furthermore, a minimum patterning resolution of 40 µm was obtained with the CNTaptamer ink. Figure 4.3C shows the scanning electron microscope (SEM) image of the CNTaptamer ink, which shows well-dispersed nanostructures that allow easy access to the aptamers by
lysozyme proteins.
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Figure 4.3. (A) Fluorescence image of the printed CNT-aptamer ink in a single-droplet array with
different numbers of layers (as indicated by the numbers in the image); and (B) the intensity profile
of the printed circles versus the number of layers. Each droplet has a diameter of 40 µm; (C) shows
an SEM image of the CNT-aptamer ink used for lysozyme recognition.
4.3.2. Characterization of the Sensor
Figure 4.4 shows the Nyquist curves of the SPCE with different modifications on the working
electrode: (a) bare device, (b) with CNT ink printed, and (c) with CNT-aptamer ink printed. When
the electrode is printed with CNT only, the charge transfer resistance (Rct) decreases due to the
highly conducting nature of MWCNT. However, when the electrode is printed with the CNTaptamer ink, the Rct increases significantly due to the negative charges of the single-stranded DNA
oligonucleotides, as well as the electrical shielding of the CNTs by the insulating DNAs.
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Figure 4.4. The Nyquist curves obtained with electrochemical impedance spectroscopy (EIS)
measurements at different modification stages of the electrode: (a) bare screen-printed carbon
electrode (SPCE); (b) printed with CNT ink; and (c) printed with CNT-aptamer ink. Aptamer
wrapping to CNTs significantly increases the charge transfer resistance (Rct) due to the negative
backbone of the DNA aptamers.
Figure 4.5 compares the responses of the printed sensor before and after exposure to the target
protein biomarker. As can be seen from the figure, when the sensor is exposed to lysozyme, Rct
decreases considerably. This can be attributed to the conformational changes of the anti-lysozyme
aptamers upon specific binding to the target, resulting in an unwrapping of the DNAs from the
CNTs. The unwrapped aptamers are then removed from the device via rinsing the electrode,
thereby decreasing the charge transfer resistance.
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Figure 4.5. Effect of lysozyme exposure on the printed sensor. Nyquist curves for (a) pre- and (b)
post-lysozyme conditions. It can be observed that lysozyme (1 µg/mL) exposure reduces the
charge transfer resistance (Rct) because of the unwrapping of the anti-lysozyme aptamers from the
CNTs to capture the lysozyme protein.
Lysozyme binding of the aptamers was further confirmed by comparing the responses of the
printed devices with those of bare SPCEs. As summarized in Figure 4.6, the change in Rct is much
larger for the printed sensor than for the bare electrode. The Rct changes in the bare electrodes are
likely due to the non-specific adsorption of the target biomarker on the electrode surface.

Figure 4.6. Change of charge transfer resistance (Rct) due to lysozyme exposure to bare SPCE
(black bars) and printed SPCE (red bars) for different lysozyme concentrations.
4.3.3. Packing Density of the Aptamer Probes
The theoretical number of aptamer probes printed on the working electrode can be calculated as
follows:
𝑛 = 𝑀 × 𝑉 × (1 − 𝜒) × 6.023 × 1023

(2)

where n is the number of aptamer molecules, M is the molarity (=5 µM) of the aptamers in the ink,
V is the volume (=1.575 µL) of ink printed (see Appendix A), and χ accounts for the fraction of
aptamers not attached to the CNT during the sonication-assisted dispersion of the CNT-aptamer
mixture and can be estimated from the experimentally calculated probe density as detailed below.
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Experimentally, the probe packing density can be calculated by the integrated Cottrell equation
[116]:
1

Q=

⁄
2nFAD0 2 Co 1⁄
t 2
√π

+ Qdl + QSE

(3)

where n is the number of electrons per molecule for reduction, F is the Faraday constant (96485.33
C/mol), A is the electrode area (cm2), Do is the diffusion constant (cm2/s), Co is the bulk
concentration (mol/cm3), t is the time (s), Qdl is the double layer capacitive charge (C/mol) and
QSE is the surface excess charge (C/mol) from the reduction of the adsorbed redox marker. QSE is
related to the density of the redox probe, ᴦ0 (mol/cm2) by the following equation [26]:
ᴦ0 =

QSE
nFA

(4)

The value for QSE can be calculated from chronocoulometry experiments. The chronocoulometric
intercept at t = 0 is the sum of the double layer capacitive charge and the surface excess charge.
The surface excess charge (QSE) is determined from the difference in chronocoulometric intercepts
(at t = 0) in the presence and absence of the redox probes for the identical potential steps. The
density of the aptamer (ᴦDNA ) is given by the following equation [26]:
𝑧

ᴦ𝐷𝑁𝐴 = ᴦ0 𝑚 𝑁𝐴

(5)

where z is the charge of each redox molecule, m is the number of nucleotides in the aptamer base
sequence, and NA is Avogadro’s number. Chronocoulometry was performed for different number
of printed layers (see Appendix A). The experimentally calculated packing density for different
number of layers is plotted in Figure 4.7. The graph shows that the packing density increases with
increasing number of printed layers, and then saturates for further number of layers. This saturation
effect can presumably be attributed to the steric and electrostatic repulsion among the negatively
charged aptamers [117].

Now if equation (2) is used to linearly fit the experimental data points of Figure 4.7, the value of
χ can be estimated as χ = 98.7%. Therefore, the number of aptamer molecules printed per layer on
the WE (area: 0.12 cm2) of the electrode can be estimated as 1.23 × 1010 molecules per layer.
Hence, the aptamer density can be calculated as approximately 1.03 × 10 12 molecules/cm2 per
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layer. Furthermore, using this value of χ, the final concentration of the aptamers present in the
printed ink can be estimated as 65 nM.

Figure 4.7. Packing density of aptamer probes as a function of number of printed layers.
The influence of the number of printed layers on the sensing performance was also characterized.
As presented in Figure A4 in Appendix A, it was observed that the sensor response experiences a
nearly linear increase (region 1) with increasing number of printed layers until it reaches a plateau
and then decreases afterwards (region 2). This is because at lower number of printed layers (region
1), the sensitivity is proportional to the concentration of aptamer receptors, i.e., more aptamers
lead to increasing binding. However, for increased number of layers (region 2), the aptamers that
are buried deep in the printed ink are not able to bind with the protein and hence remain as electrical
insulators, resulting in poor sensitivity. The plot in Appendix A illustrates the influence of the
number of printed layers on the sensor’s sensitivity. Also, the sensor’s response time correlates
with the thickness of the printed layers, in other words, the number of prints on the electrode. In
our experiments, all devices were printed five times for lysozyme detection.

4.3.4. Performance of the Aptamer Sensor
The performance of the aptamer sensor has also been characterized by measuring the relative
change in sensor response for different concentrations of lysozyme analyte. The results are
presented in Figure 4.8, where each sensor contains five layers of printed CNT-aptamer ink.
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Figure 4.8. (a)–(h) Pre- and post-lysozyme Nyquist curves for different concentrations of lysozyme
(0, 0.25, 0.5, 1, 2, 5, 10, 20 µg/mL, respectively) in 50 mM PBS as well as (i) post-lysozyme
Nyquist curves for all the lysozyme concentrations.
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4.3.5. Modelling of the Nyquist Curves
The pre- and post-lysozyme Nyquist curves can be modelled by the modified Randles circuit
shown in Figure 4.9, where RS is the solution resistance, Rct is the electron transfer resistance, CPE
(constant phase element) represents the double layer capacitance at the solution–electrode interface
for a rough surface [118], and W1 is the Warburg impedance.

Figure 4.9. Modified Randles circuit representing the equivalent circuit model to fit the Nyquist
curves of the EIS measurements.
The CPE accounts for the roughness of the electrode surface and, mathematically, its impedance
is (ZCPE) described by the following equation [119]:
ZCPE =

1
Q1 × (jω)α1

(6)

where j is the imaginary unit, and α1 and Q1 are the characteristic parameters of the constant phase
element. The introduction of the CPE instead of a simple capacitance is particularly important for
the modelling of primary protein layers on the electrode surface, and the parameter α1 was found
to vary between 0.925–0.961 for our sensor devices. For α1 = 1, the CPE turns into a simple
capacitance. W1 is the circuit element corresponding to Warburg impedance resulting from the
semi-infinite diffusion of ions from the bulk electrolyte to the electrode interface and is
mathematically given by [120]:
ZW1 =

√2 δ1
√jω

(7)

where δ1 is the characteristic value of the Warburg element. Table 4.1 summarizes the modified
Randles circuit parameters of the post-lysozyme Nyquist curves of Figure 4.8I.
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Table 4.1. Randles circuit parameters for the post-lysozyme Nyquist curves in Figure 4.8I (Data
extracted using Zfit program of Bio-Logic EC-Lab software).
Lys Concentration

Rct (ohms) CPE (µF∙sn−1)

α1

Rs (ohms)

δ1
(ohm∙s1/2)

(µg/mL)
0

10511

4.734

0.962

186

2086

0.25

7850

4.567

0.963

172

2154

0.50

7251

6.158

0.944

178

1928

1

5359

5.313

0.943

185

1833

2

3028

4.917

0.968

175

1554

5

2064

4.449

0.970

178

1501

10

1869

5.518

0.969

189

1542

20

1435

5.526

0.961

192

1491

Figure 4.10 shows the theoretically fitted post-lysozyme Nyquist curves based on the modified
Randles circuit (red solid lines). The dotted lines represent the experimental data. The graph shows
good agreement between the experimentally obtained Nyquist curves and those obtained from the
theoretical model.

Figure 4.10. Post-lysozyme exposure Nyquist curves for different concentrations of lysozyme: (a)
0 µg/mL; (b) 0.25 µg/mL; (c) 0.50 µg/mL; (d) 1 µg/mL; (e) 2 µg/mL; (f) 5 µg/mL; (g) 10 µg/mL;
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and (h) 20 µg/mL. The dotted lines are the experimental data and the solid lines in red are the
theoretically fitted curves based on the modified Randles circuit.
The calibration curve for our aptamer-based sensor is presented in Figure 4.11. It shows that for
low concentrations of lysozyme, the sensor exhibits high sensitivity and at higher concentrations
(5 µg/mL and above) the sensor’s response reaches a saturation. Based on this calibration curve,
the detection limit was calculated to be 90 ng/mL. (See Appendix A for the formula used for
calculation).

Figure 4.11. Relative change in charge transfer resistance (Rct) after lysozyme exposure with
varying concentrations (0, 0.25, 0.50, 1, 2, 5, 10, and 20 µg/mL). Error bar shows 1 standard
deviation with n = 3. The inset graph shows the magnified plot for low concentration range from
0 to 5 µg/mL.
4.3.6. Selectivity of the Aptamer Sensor
The selectivity of our aptamer-based lysozyme sensor was investigated against two other proteins:
thrombin (THR) and bovine serum albumin (BSA). It is clear from Figure 4.12 that our aptamerbased biosensor is highly selective toward lysozyme. The non-zero responses for THR and BSA
can be attributed to the non-specific adsorption of the proteins on the sensor. Although the
aptamers were designed to selectively bind with lysozyme, THR and BSA do have some level of
affinity with the aptamers, resulting in a false recognition of the analyte. However, the non-specific
binding efficiencies are significantly lower than that of lysozyme, hence the signal responses are
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markedly smaller compared to the specific target recognition by lysozyme. Better optimization of
the aptamer sequence is expected to further enhance the target selectivity. For instance, a 42-mer
aptamer sequence (ATC TAC GAA TTC ATC AGG GCT AAA GAG TGC AGA GTT ACT
TAG) is reported to have improved binding efficiency [121], which could further reduce the
response from THR and BSA.

Figure 4.12. Selectivity of the aptamer biosensor to lysozyme against other proteins such as
thrombin and bovine serum albumin for different concentrations.
4.3.7. Long-Term Stability (Shelf-Life) of the Aptamer-Printed Biosensor
The shelf-life or the long-term storage stability of the developed biosensor was investigated by
storing the fabricated devices for a period of up to 35 days at room temperature. After the storage
period, the sensor was tested by measuring the Nyquist curves for the pre-exposure and postexposure measurements with the lysozyme concentration of 1 μg/mL. As can be seen from Figure
4.13, the sensor response is reasonably consistent (with a tolerance of ±1.73%) for the first 21
days, then experiences a drop in the resistance change afterwards. Hence, it can be concluded that
our proposed sensor is stable for 21 days at room temperature. However, it is expected that the
shelf-life would be further extended if the devices were stored in a cooler temperature, such as at
4 °C. Moreover, because we are utilizing an inkjet-printed sensor, one advantage is that the sensor
can be printed on-demand so that the storage time can be minimized.
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Figure 4.13. Shelf-life of the fabricated aptamer-based biosensor. The sensor response is plotted
against the number of stored days at room temperature.
4.3.8. Comparison to Other Aptamer-Based Lysozyme Sensors
In order to compare the sensing performance presented in this work with other recently reported
lysozyme sensors, Table 4.2 summarizes the detection limit (LOD), linear range, immobilization
method, and detection mechanism of several recently published works. The table demonstrates
that the sensor presented in this work shows comparable performances with other reported sensors.
However, the main advantage and novelty of the proposed device is the convenience and the ease
of immobilizing and patterning the aptamers on the electrode using the precision inkjet-printer for
low-cost and disposable sensor development.

Table 4.2. Comparison of the sensing performances of recently published lysozyme sensors.
LOD

Linear Range

Immobilization

Detection

Technique

Mechanism

Ref.

12.09 µg/mL

0–200 µg/mL

Covalent

EIS

[54]

1.4 fg/mL

1.4 fg/mL–14 ng/mL

Thiol-Gold

SWV

[97]

7 ng/mL

14 ng/mL–1.12 µg/mL

Thiol-Gold

SPQC

[59]

0.14 fg/mL

1.4 fg/mL–6.96 pg/mL

Thiol-Gold

EIS

[26]

200 ng/mL

0–10 µg/mL

Biotin-Avidin

EIS

[108]

76.6 fg/mL

98.2 pg/mL–49.1 ng/mL

π–π stacking

DPV

[122]
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0.4 pg/mL

1–50 pg/mL

Covalent

SWV

[123]

90 ng/mL

0–1.0 µg/mL

π–π stacking

EIS

This work

4.4.

Conclusions

An inkjet-printed aptamer-based biosensor has been developed for the label-free selective
detection of lysozyme biomarker. Electrochemical impedance spectroscopy was used as the
interrogation method. The selectivity of the sensor was tested against BSA and thrombin and was
shown to be selective towards lysozyme. The limit of detection was calculated to be 90 ng/mL.
The sensor also demonstrates a reasonable shelf-life of around 21 days at room temperature.
Although we have demonstrated the feasibility of inkjet printing-based sensor development for
lysozyme detection, our next step in the future work is to further characterize this sensing platform
with real physiological samples such as saliva or blood serum to ensure that the results can be
replicated. The proposed inkjet-printed biosensor has potential applications in point-of-care
diagnostics by enabling low-cost, label-free, fast detection, and on-demand printability so that
patient-centered healthcare can be delivered through a disposable disease diagnostic and screening
kits.
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GRAPHENE FET AS A SENSITIVE
DETECTION PLATFORM FOR BIOSENSOR
5.1.

Introduction

Lysozyme is a ubiquitous enzyme that is widely available in diverse organisms, such as bacteria,
bacteriophages, fungi, plants, and mammals. Being an antimicrobial protein, lysozyme is often
called the “body’s own antibiotic” [59], [96]. The protein is also extensively exploited in food
industries for several purposes such as preserving meat and dairy products, as well as fruits and
vegetables. The molecular weight of lysozyme is 14,400 Da with a primary sequence containing
129 amino acids and it has an isoelectric point of 11.0 that causes lysozyme to behave as positively
charged at neutral pH [96]. In addition to its extensive use in food industry, lysozyme also plays a
vital role as a biomarker for diagnosing various diseases such as breast cancer [98], Alzheimer’s
[99] and rheumatoid arthritis [100].

In the past, several biosensing techniques have been deployed for effective detection of lysozyme
molecules. Some of these methods include chromatographic or antibody-based techniques [124],
sensitive colorimetric detection [125], surface plasmon resonance (SPR)-based approach [126] and
electrochemical impedance spectroscopy (EIS) measurement [127], [128], to name a few. Among
these sensing techniques, field-effect transistor (FET)-based sensing offers several advantages
including miniaturization, low cost, and large-scale integration with other sensors as well as rapid
detection and high sensitivity [129]–[131].

A typical FET biosensor is comprised of a semiconducting channel contacted between the source
and the drain electrodes. Upon adsorption of the biomolecules on the semiconductor surface, a
change in the electric field occurs which affects the gate potential of the device resulting in a
change in the charge carrier density within the channel of the FET. Such change in the drain current
can be conveniently measured and be utilized as an interrogation strategy to probe the adsorbed
biomolecules. This type of sensing mechanism has been demonstrated in the past for detecting
target analytes in gases, water as well as in human serum [28]–[31], [89]. Two-dimensional (2D)
nanomaterials such as such as graphene, MoS2, WS2 etc. are particularly attractive as a channel
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material for FET-based biosensors due to their planner structure, excellent electrical properties,
and high surface area-to-volume ratio. Among several 2D materials graphene has been widely used
as a promising FET channel material for various analyte detection due to its superior physical and
chemical properties: namely high intrinsic carrier mobility, good biocompatibility, high stability,
and flexibility, which are all desirable traits to have for biosensing applications. For example,
chemical vapor deposition (CVD)-grown graphene-based FET (GFET) biosensors have been used
to detect triphosphate [132] and binding kinetics of DNA hybridization [88]. Similarly, Huang et
al. and Chen et al. have successfully demonstrated the detection of bacteria [133] and Ebola antigen
[134] using graphene-based FETs. Nonetheless, the detection of protein molecules using FET
biosensors is largely limited by the charge screening effects of the non-specifically adsorbed
surface molecules from the buffer solution. To overcome this issue, the graphene channel surface
is typically modified with target receptors which enable specific binding reaction with the charged
target protein molecules in the solution. For example, Ohno et al. reported that in an aptamermodified GFET, a non-specific binding of the non-target protein molecules was suppressed [135].
However, this technique is still limited for specific detection of small and weakly-charged analytes
which do not directly induce detectable changes in surface charge after molecular binding.
Moreover, the detection of lysozyme protein via a GFET-based biosensing platform has not yet
been demonstrated so far. Therefore, in this work, we describe the selective detection of lysozyme
molecules utilizing large area CVD-grown GFET devices prepared by a facile one step transfer
process.

The fundamental operating principle of the GFET biosensor is illustrated in Figure 5.1. Figure
5.1(a) depicts the schematic of the liquid-gated GFET device. CVD-grown large area graphene is
contacted with source and drain electrodes. Single-stranded probe DNAs (pDNA), which act as
target-binding aptamers, are securely anchored onto the graphene surface, via the bifunctional
linker 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE). A sample ionic buffer solution
is dropped on the surface of the GFET channel. Upon applying a gate voltage (VGS), between the
gate electrode in the solution and the source electrode of the GFET channel, the electrical double
layer (EDL) is formed at the interface between the graphene channel and the electrolyte [136].
This formation of EDL induces image charges in the channel and provides high gate capacitance.
This gating capacitance provides the source of electrostatic gating of the GFET. Figure 5.1(b)
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demonstrates the IDS-VGS characteristics of the GFET. A typical ambipolar electric field-effect
characteristics is expected for the top-gate operation with -1 V ≤ VGS ≤ 1 V. The minimum IDS
occur at the charge neutrality point VCNP also known as the Dirac voltage (VDirac), which signifies
the demarcation between the p-type and the n-type conduction of the graphene channel. Therefore,
the VCNP represents the doping level in the graphene channel. Since the surface-analyte or analyteanalyte bindings occur in the proximity of the graphene surface, the analyte-analyte bindings can
significantly change the doping level in the graphene channel. This change in the doping level
results in a detectable shift in VCNP as shown in Figure 5.1b.

Figure 5.1. (a) Schematic representation of top liquid-gated graphene FET device with anchored
pDNAs on the graphene channel surface. (b) IDS-VGS characteristics of graphene FET device
before and after target molecule binding resulting in a detectable change in VCNP.

5.2.

Materials and Methods

5.2.1. Materials
The amino linker modified anti-lysozyme DNA oligonucleotide (sequence designed by Ellington
and co-workers [113] was synthesized by Sigma-Aldrich. The sequence of the oligonucleotide is:
5′ -amino-C6-ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG-𝟑′ . Lysozyme protein from
chicken egg white was also purchased from Sigma-Aldrich. Protein stock solutions were prepared
by dissolving the lyophilites in fresh ultrapure triple-distilled deionized water and stored at -20˚C.
The diluted solutions of proteins were prepared in 50 mM Phosphate buffer solution (PBS, pH
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7.4). PBS was obtained from Sigma-Aldrich. Tween 20 and 1-pyrenebutyric acid Nhydroxysuccinimide ester (PBASE) were purchased from RPI Research Products International
(IL, USA) and Santa Cruz Biotechnology (TX, USA), respectively.
5.2.2. Fabrication of GFET
Figure 5.2 shows the transfer process of large area CVD grown graphene from SiO2/Si substrate
onto the prefabricated 4 independently addressable gold electrodes. The CVD grown graphene
sample was purchased from Graphene Supermarket (NY, USA). The transfer process begins with
spin coating onto the graphene a support layer of poly (methyl methacrylate) (PMMA) at 3000
RPM followed by immersion into 6 M KOH solution for 30 min at 800C. This results in etching
of the underlying SiO2 layer and separation of the top PMMA/graphene bilayer from the substrate.
The PMMA-protected graphene layer was then collected on top of the pre-fabricated gold
electrodes and dried at room temperature. The electrodes were then immersed into acetone for 12
hours to dissolve the top PMMA layer followed by consecutive washing with ethanol and DI water.
Finally, the devices were annealed at 250°C for 2 hr in an Argon-filled chamber to reduce any
PMMA residues [137].

Figure 5.2. Schematic illustration of large area CVD-graphene FET device fabrication process.
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5.2.3. Electrical FET measurements
All electrical measurements were carried out using the Keysight precision source/measure unit
(B2902A) combined with a probe system (Micromanipulator: 450PM-B). For FET measurements,
solution-gate experiments were performed. A constant bias voltage VDS = 100 mV was applied
across the drain and the source terminals by connecting the two manipulator needles to the source
and the drain electrodes. The gate voltage VGS (-1 V≤ VGS ≤ +1 V) is applied by immersing the
third manipulator needle into the sample droplet of 0.01× PBS buffer solution placed on top of the
GFET devices.
5.2.4. Functionalization of GFET
Immobilization of the pDNAs onto the graphene surface was performed by incubating the
graphene chip in the bifunctional linker 1-pyrenebutyric acid N-hydroxysuccinimide ester
(PBASE) at 10 mM in dimethyl formamide (DMF) at room temperature for 20 hr. The aromatic
pyrenyl group of PBASE binds to the basal plane of graphene through noncovalent π − π
interactions [138]. This was then followed by rinsing the chip sequentially in DMF, ethanol and
DI water for 3 min each. In the final step, the chip was incubated with the aminated (5’) probeDNA at 5 µM in 0.01× PBS at room temperature for 12 hr to covalently link the pDNA to the
PBASE via an N-hydroxysuccinimide (NHS) crosslinking reaction [139]. To remove the
unanchored pDNAs, the chip was successively rinsed with 0.1× PBS and DI water. Following the
probe attachment, the chip was treated with 0.1% Tween 20 followed by sequential rinsing in
0.05% Tween 20 and DI water. Finally, the chip was incubated in different concentrations of target
proteins in 0.1× PBS for 30 min. This allows lysozyme binding due to the sequence-specific high
affinity of the aptamers to lysozyme [23], [54]. Afterward, the chip was rinsed with 0.01× PBS
buffer followed by DI water and dried with a compressed air gun before performing the electrical
measurements.

5.3.

Results and Discussion

5.3.1. The effects of functionalization and DNA immobilization on the FET measurements
For the selective protein detection, the graphene layer is successively functionalized by PBASE
and the single-stranded probe DNAs (pDNAs) specifically designed for lysozyme binding [113].
The GFET devices were configured as electrolyte-gated FETs where the graphene is the
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conducting channel formed between the source and the drain electrodes on the SiO2/Si substrate
as schematically depicted in Figure 5.1(a). PBS solution (0.01×) was used as the top gating
dielectric. The pyrene group terminated PBASE is coupled to the graphene surface via the π-π
stacking forces [88]. The 5′ - amino-modified pDNAs were attached to the amine-reactive
succinimide group of PBASE by the conjugation reaction between the amine groups. The IDS−VGS
characteristics of the GFET devices were measured sequentially after each functionalization step
and exposure to the target lysozyme molecules. The binding of the lysozyme molecules to the
pDNAs induces changes in the charge carrier density in the graphene channel. This causes a
detectable change in the Dirac voltage (VDirac) or the charge neutrality point (VCNP) in the IDS−VGS
characteristics of the GFET.

Figure 5.3 shows the IDS-VGS characteristics of a GFET device at each stage during the surface
modification process. The IDS-VGS characteristics exhibit ambipolar behavior as the gate voltage in
the top-gate dielectric (0.01×PBS) changes from -1 V to +1 V similar to previously reported
measurements [88]. The VCNP for the unmodified GFET was found to be 203.96 mV. Since the
graphene channel is sensitive to any surface adsorptions or modifications, the VCNP was shifted left
at 40.8 mV relative to the unmodified graphene channel after the PBASE linker modification.
Previously, Wu et al. reported that PBASE modification of graphene causes n-doping in the
graphene channel after long incubation in the DMF solvent [140]. Therefore, left shift of VCNP in
our experimental results suggests n-doping of the graphene channel. Figure 5.3(c) shows the IDSVGS characteristics of the GFET after the pDNA attachment. Here, we note that the VCNP further
shifted left with respect to that after PBASE modification (Figure 5.3(b)) indicating further ndoping of the graphene channel. It has been widely observed and speculated that the presence of
electron rich nucleotide bases in the DNA molecules can cause n-doping effects in carbon
nanotubes and graphene [141], [142]. We have further treated the GFET devices with 0.1% Tween
20 solution in deionized water in order to minimize non-specific adsorption. Due to its high affinity
with graphene, Tween 20 has been extensively used in the past to deter non-specific binding of
proteins as well as to remove non-specifically adsorbed probe DNAs on the graphene [139].
However, the presence of the surfactant adsorbates can effectively dope the graphene channel.
Among various surfactants, Tween 20 has been reported to cause n-doping effect on the graphene
[143]. Further negative shift of VCNP in the IDS-VGS curve after Tween 20 treatment thus is
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consistent with an increased n-doping effect as indicated in Figure 5.3(d). We further notice a
small change in the minimum current at VCNP that after each step of functionalization. Due to
atomically thin nature, the minimum conductance at the charge neutrality point VCNP in GFET
devices are extremely sensitive to several extrinsic factors such as charge impurities, doping
density, external ions etc. [144], [145]. Previously it was also reported that the minimum
conductance can also be affected by the presence of PBS buffer ions [141]. Thus, we believe that
the small changes in the minimum current at VCNP in our GFET devices are caused due to doping
effect after surface modification and/or due to the ionic adsorption or desorption effects of the PBS
buffer ions.

Figure 5.3. IDS-VGS characteristics of the graphene FET device (a) before any surface modification
(unmodified graphene); (b) after PBASE functionalization; (c) after attaching single-strand
pDNAs to the PBASE linker; and (d) after treating the graphene surface with 0.1% Tween 20.

5.3.2. Concentration Dependent Shift in the Charge Neutrality Point
Figure 5.4(a) shows the IDS-VGS characteristics of the GFET device when exposed to varying
concentrations of lysozyme samples. The graphene devices were first incubated in 0.01× PBS
buffer solution containing the lysozyme protein for 30 mins followed by a gentle wash in PBS and
deionized water before the FET measurements were performed. We found that after exposure to
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10 nM lysozyme solution, the VCNP shifted to -449 mV. This results in a positive shift of VCNP of
20.5 mV with respect to the VCNP = -469.5 mV at 0 nM lysozyme. VCNP shifts further right with
the increasing lysozyme concentration. The lysozyme binding with the pDNA aptamer (5′ -aminoC6-ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG-3′ ) was previously confirmed by
[96]. It was also found that at neutral pH, lysozyme is positively charged with net +8 charges [96],
[146]. Therefore, the presence of lysozyme molecules in the proximity of the graphene nanosheet
can induce a p-doping effect in the FET channel. Thus, the positive shift of the VCNP can be
attributed to the reduction of n-doping effects during the previous functionalization steps. Further,
our results suggest a strong correlation between the lysozyme concentration and the degree of the
VCNP shift in the right direction: the higher the lysozyme concentration, the further the VCNP shifts
to the right. Figure 5.4(b) shows the relative shift of VCNP (ΔVCNP) (with respect to the position of
VCNP after exposure to 0 nM lysozyme concentration) after exposing the GFET devices to a series
of lysozyme concentrations in the range from 10 nM to 10 µM. From the FET responses, we have
found that ΔVCNP increases sharply for the lower concentrations of lysozyme and then gradually
reaches saturation at approximately 1µM and beyond.

Figure 5.4. (a) IDS-VGS characteristics of the graphene FET-based biosensor device when it is
exposed to varying concentrations of lysozyme protein; (b) the calibration curve for the GFETbased biosensor showing ΔVCNP as a function of different concentrations of lysozyme. The
sample set is 𝒏 = 𝟑, and the error bar represents 1 standard error.
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To further verify the specific lysozyme binding with the pDNA aptamers and subsequently to
characterize the selectivity of the GFET biosensor devices, we also prepared GFET devices but
without the presence of pDNAs. After successive functionalization with PBASE linker and 0.1%
Tween 20, the devices were exposed to 1 µM lysozyme solution. The IDS-VGS curves obtained
from the GFET without pDNAs are shown in Figure 5.5(a). Here we found that, after exposure to
the lysozyme molecules, there is only a very small shift in VCNP (ΔVCNP =10 mV). This slight
change in VCNP can be attributed to the small amounts of non-specific surface adsorptions of the
lysozyme proteins on the surface of the graphene sheet. Similarly, we tested pDNA functionalized
GFET devices against another non-specific target protein bovine serum albumin (BSA). As
expected, due to the lower binding affinity of the pDNA aptamers with BSA, negligible changes
in VCNP were observed. Figure 5.5(b) compares the overall sensor responses of the three GFETs,
two with the pDNA modification against lysozyme and BSA and one without the presence of
pDNAs against the lysozyme (3 separate devices in each group). These results clearly indicate that
our graphene-pDNA FET devices can selectively detect lysozyme molecules with significant
changes in the charge neutrality point.
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Figure 5.5. (a) IDS-VGS characteristics of graphene-PBASE FET (without pDNA) device before
and after exposure to 1µM lysozyme; (b) Comparative bar-chart showing the ΔVCNP of the
graphene-PBASE FET devices with the pDNA functionalization after exposure to 1µM lysozyme
and 1µM BSA and without pDNA functionalization (n = 3, error bar = 1 standard deviation, paired
Student’s t-test, ***p < 0.001).); (c) the schematic diagram of the GFET with pDNAs (left) and
without pDNAs (right).

5.4.

Conclusion

We have presented aptamer-modified large area CVD-grown graphene FET biosensor for the
detection of lysozyme protein biomarker. The FET biosensor is sequentially functionalized with
PBASE crosslinker, an aptamer specifically designed for the molecular recognition of lysozyme
protein and Tween 20 as a blocking agent for minimizing non-specific adsorptions on the graphene
channel surface. We have demonstrated that the lysozyme molecules have specifically bound to
the surface immobilized aptamers causing a disruption in the charge carrier density. This resulted
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in the shifting of the charge neutrality point. Consequently, this change in the charge neutrality
point potential of the graphene-FET devices was utilized to quantify the bound lysozyme
concentration. The graphene-FET biosensor devices were tested for the detection of the lysozyme
biomarker with concentrations ranging from 10 nM to 1 µM in the PBS buffer, demonstrating its
capability as a specific biomarker sensor. Furthermore, the dynamic drain-source current
measurement with respect to varying lysozyme concentrations would be essential for the
demonstration of real-time monitoring of lysozyme molecules. In terms of health diagnostics
application, this technology can potentially be used for facile development of large-scale point-ofcare testing kits for low-cost and fast-readout disease screening and diagnostics.
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GFET-MICROFLUIDICS AS AN
INTEGRATED PLATFORM FOR REAL-TIME
BIOSENSING
6.1.

Introduction

Graphene, a 2D material of one atomic layer thickness, shows a plethora of interesting properties
[147]–[154] such as high carrier mobility, large specific surface area, excellent electrical
conductivity, planar structure, potential biocompatibility, high stability and flexibility. As a result,
graphene materials have been used in many electronic applications including photodetectors [149],
[150], capacitors [152] as well as biosensors [153]. Specifically, the utilization of graphene as a
conduction channel in a field-effect transistor (FET) has been shown by us and others to have
potential for sensitive biodetection [27], [154], [155][29]. To date, there exist many different
detection principles in biosensors such as electrochemical impedance spectroscopy [23], [54],
[106], high-performance liquid chromatography (HPLC), quartz crystal microbalance (QCM)
[156], [157], surface plasmon resonance (SPR) [158] and fluorescence based optical detection
[159], [160] to name a few. However, there are some limitations with these techniques such as
tedious sample preparation as well as sophisticated and expensive instrumentation with consistent
need for trained operators. By contrast, FET-based detection offers a variety of advantages such
as high sensitivity, fast detection time, easy integration with the integrated circuit (IC)
manufacturing process, miniaturization, low-cost, continuous real-time sensing and label-free
detection [129]–[131].

A Graphene FET (GFET) biosensor works either by the electrostatic gating effect or direct charge
transfer to graphene, also known as the doping effect, or a combination of both [79], [89]. In the
case of electrostatic gating, any adsorption of charged biomolecules on the channel surface causes
a change in the electric field that modulates the current through the channel between the source
and the drain. By contrast, the doping effect changes the channel conductance as a result of direct
charge transfer between graphene and the biomolecule in contact with the graphene surface [141],
[161], [162]. The competition between the doping effect and the gating effect determines the
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appropriate sensing response. For example, if the doping effect is dominant, the current increases
in a p-type semiconducting channel, whereas if the gating effect is dominant, the conduction
current decreases [89]. This change in the drain current can be utilized as an interrogation strategy
to probe the adsorbed biomolecules. Moreover, the ambipolar transfer (drain current vs. gate
voltage) curve of the GFET devices provides an additional sensing mechanism by measuring the
surface charge-induced shift in the Dirac voltage (∆VDirac) which is defined as the gate voltage at
minimum drain current. Hence, the GFET as a biosensing platform has been applied for the
detection of various target analytes including antigens, antibodies and charged molecules [27],
[32], [79], [82], [83], [88], [163].

Thrombin is an important protein biomarker for a number of diseases as it plays a central role in
several cardiovascular diseases and the regulation of tumor growth. It is also responsible for
thrombosis and platelet activation and therefore, is involved in many processes such as
inflammation and tissue repair at the blood vessel wall [164]. Hence, the selective and sensitive
detection of thrombin will be useful in surgical procedures and cardiovascular disease therapy.
Moreover, thrombin is positively charged [165], [166] at neutral pH enabling it to be detected on
a graphene-based sensing platform. Existing thrombin biosensors commonly use either antibodies
or aptamers as the target capture probe to enhance selectivity. Recently, aptamers have become a
popular choice of target receptors due to a number of advantages they offer compared to antibodies
including shorter length and simpler structure, lower cost, higher stability in harsh environmental
conditions, longer shelf-life and mass-producibility. Moreover, they can be selected in-vitro with
high affinity for a wide range of analytes ranging from proteins, peptides, amino acids, drugs,
metal ions and to even whole cells [9].

Although GFET-based biosensors have been frequently reported [27], [167], [168], when it comes
to analyte liquid control, a small volume of sample droplet is often placed over the graphene
surface to form a liquid gate which is exposed to the open atmosphere. This type of sensing
arrangement makes the sample loading and disposal difficult to control and also makes the device
vulnerable to external disturbances such as evaporation. These factors could lead to inaccurate
measurements and poor sensing performances. Furthermore, measurements taken during static
flow (non-moving fluid) may lead to the mass-transfer limitation in the kinetic binding processes
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[169]. Therefore, in efforts to address such challenges, the integration of the GFET device with a
microfluidic system is implemented.

The integration of microfluidics to biosensors has emerged as a promising approach in biomedical
applications as microfluidics offer numerous advantages over traditional assays. Conceptually,
microfluidics is the manipulation of fluids in submillimeter length scale with technologies first
developed by the semiconductor industry and later expanded by the micro-electromechanical
systems (MEMS) field. Commonly known as miniaturized Total Analysis System (µTAS) or Labon-a-Chip (LoC) technologies, microfluidic technologies have been applied to biomedical research
in order to (1) streamline complex assay protocols, (2) to reduce the sample volume and detection
time substantially, (3) to reduce the cost of reagents while maximizing the information collected,
(4) to enable automated measurement with high throughput, (5) to potentially enhance the
sensitivity by increasing surface-to-volume ratio, and (6) to enable portability, disposability and
real-time detection [170]–[172]. Moreover, integration to microfluidic channels improves the
accuracy of measurements by preventing evaporation of buffer solution [173]. To exploit these
advantages of the microfluidic technology, the integration of GFET biosensors and microfluidics
has been proposed by several research groups. For example, Islam et al. have developed a
microfluidic GFET biosensor for femtomolar detection of chlorpyrifos [163]. Yang et al. have
built a microfluidic aptasensor that combines aptamer-based selective analyte enrichment, isocratic
elution with GFET-based nanosensing for sensitive and label-free detection of small biomolecules
[174]. Saltzgaber et al. have demonstrated a large-scale GFET fabrication using a CVD-grown
graphene layer and the detection of thrombin biomarkers [175]. Therefore, GFET-based thrombin
sensing has the potential to be used as a point-of-care diagnostic device. However, for this to be
used reliably in a real-world setting, the GFET must achieve the limit of detection, sensitivity, and
analyte selectivity required for clinical use. As an example, thrombin concentration in blood can
change from picomolar to micromolar range depending on the health condition. Therefore, a
thrombin biosensor must exhibit a limit of detection in the picomolar level as well as a detection
range up to a micromolar concentration [176].

In this work, we demonstrate that the aptamer-modified microfluidic GFET platform can
selectively detect the thrombin biomarker with a detection limit in the picomolar range. Detailed
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analyses of the sensing performances as well as device characterization, including aptamer packing
density and continuous real-time sensing, are presented. The GFET was fabricated using the CVDgrown graphene transferred on prefabricated gold electrodes. In contrast to the mechanical
exfoliation technique which yields higher quality of graphene, the CVD-based graphene allows
large-scale production of graphene with controllable sensing area [148], [177]. Then, the GFET
module was integrated with a microfluidic chip to build a miniaturized and portable biosensing
module. The detection was performed by measuring the change in the Dirac voltage (∆VDirac). Our
biosensor was able to detect thrombin with a concentration as low as 2.6 pM (~260 NIH
microunits/mL), which is significantly lower than previously reported values [107], [178]. The
binding affinity between the aptamer and the thrombin was quantified by calculating the
dissociation constant which was confirmed by transient measurements in real-time.

6.2.

The Principle of Operation of the Microfluidic GFET-Based Biosensor
Platform

The working principle of the microfluidic thrombin biosensor is illustrated in Figure 6.1. Figure
6.1A shows the schematic view of the integrated GFET device where a microfluidic channel with
an inlet and an outlet traverses the source, drain and an in-plane gate electrode. Figure 6.1B depicts
the three-electrode transistor device setup where the FET measurements were performed by
applying a constant drain voltage (VDS) between the source and the drain, whereas a varying
voltage (VGS) was applied on the gate. Figure 6.1C shows the mechanism by which target binding
and detection is achieved. The Dirac voltage shifts either to the left or right depending on the type
and concentration of the adsorbed charged species. If the adsorbed species are at low concentration
or weekly charged, doping effect dominates while gating effect becomes dominant at high
concentration or strongly charged species [79], [89]. In our experiments, while thrombin, which
has an isoelectric point of around 9.5, was weekly and positively charged at pH 7.4 [165], [166],
p-type doping was generated in graphene upon binding to the thrombin aptamer. This p-type
doping causes the Dirac voltage to shift in the positive direction [88]. By monitoring the shift in
the Dirac voltage, the presence of thrombin can be measured quantitatively.
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Figure 6.1.Conceptual illustration of the microfluidic GFET biosensor: (A) Schematic illustration
of the integrated device; (B) GFET device setup with drain, source, and gate electrodes; and (C)
The sensing mechanism based on surface charge-induced Dirac voltage shift (ΔVDirac) in the FET
ID-VGS transfer characteristics curve.

6.3.

Materials and Methods

6.3.1. Materials
The aminated anti-thrombin DNA aptamers and the aminated anti-lysozyme aptamers (for control
experiments in Appendix C) were purchased from Sigma-Aldrich. The aptamers were amineterminated with the following sequence:
Anti-thrombin: 5՛–NH2–(CH2)6–CCA TCT CCA CTT GGT TGG TGT GGT TGG-3՛ [107].
Anti-lysozyme: 5՛–NH2–(CH2)6–ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG-3՛
[113].
Thrombin from human plasma was also purchased from Sigma-Aldrich. The protein stock
solutions were prepared by dissolving the lyophilites in deionized water to achieve the different
molar concentrations needed for the experiment and were stored at 4ºC. The diluted solutions for
sensing experiments were prepared by adding 0.01×PBS (pH: 7.4) to the stock solution. Since
GFETs can only observe changes in the charge density that occurs within the distance similar to
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the Debye length from the graphene surface, it is critical to ensure that the Debye length be
sufficiently large. For an effective GFET-based sensing, the Debye length should theoretically be
comparable to the aptamer length [88]. In this work, the estimated length of the anti-thrombin
aptamer is approximately 9.1 nm. While 1× PBS has a Debye length of 0.7 nm, the Debye length
for 0.01× PBS is 7.3 nm [88], [179]. For this reason, 0.01× PBS was chosen as a running buffer
for the electrical measurements. The CVD-grown graphene sheets were purchased from
Graphenea Inc. as Easy Transfer Monolayer Graphene on a polymer film.

6.3.2. Device Fabrication, Surface Functionalization, and Measurement Methods
6.3.2.1.

Device Fabrication

For the fabrication of the FET devices, gold electrodes for the source, drain and gate contacts
were patterned on a SiO2/Si substrate using conventional microfabrication techniques. Briefly,
chromium (Cr, 5 nm) and gold (Au, 60 nm) films were thermally evaporated onto the substrate.
Then the source, drain and gate contact regions were formed by standard photolithography,
followed by wet chemical etching of Cr/Au layers. The Cr layer was used as an adhesion promoter
between Au and SiO2. After the electrode fabrication, a 5 mm × 5 mm graphene film was
transferred onto the electrodes (See Appendix C for details).
The microfluidic channel with a dimension of 30 mm × 600 µm × 100 µm was fabricated
with a polydimethylsiloxane (PDMS) block using the cast molding technique [180]. The inlet and
the outlet of the channel were formed with metal tubing and the PDMS block was securely clamped
to the GFET device. A photograph of the final integrated GFET module is shown in Figure 6.2A.
The inlet and outlet of the device were connected with silicone tubes for analyte injection and
removal. A motorized syringe pump (Harvard Apparatus) was used for driving the analyte
solutions from syringes. Such a setup enables stable flow of the analyte solution and minimizes
noise induced by liquid loading processes, as required for real-time, precise measurement of
kinetic processes for aptamer-protein binding interaction.

74

Figure 6.2. Device fabrication and graphene functionalization steps: (A) Photograph of the
microfluidic-integrated GFET module (left) and the enlarged view of the source-drain electrodes
of the right GFET array (right); and (B) Schematic illustration of the surface functional steps
applied to the GFET devices before using it as sensors.
The module consists of two GFET arrays, each array containing 3 GFET devices formed by 4
equally spaced (50 µm gap) gold electrodes (100 µm wide) with two adjacent electrodes acting as
the source and the drain. For the 3 GFET devices in each array, one in-plane gold electrode
(approximately 6.0 mm spaced apart from the 4 electrodes) serves as the gate. Table C1
summarizes the labeling of the 6 GFET devices in the module.

6.3.2.2.

Surface Functionalization

Prior to using the GFET devices as biosensors, the graphene surface was functionalized in several
steps as shown in Figure 6.2B. First, the graphene was treated with 10 mM 1-pyrene butyric acid
N-hydroxysuccinimide ester (PBASE) solution in dimethyl formamide (DMF) delivered via the
microfluidic flow system for 12 hours. The PBASE molecules were non-covalently coupled to the
graphene surface by π-π stacking interactions between complementary aromatic rings in the
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graphene and the pyrene functional group of PBASE [138]. The fluidic channel was then rinsed
by flowing DMF, ethanol and DI water sequentially to remove any unbound PBASE. Next,
aptamers were introduced into the channel by flowing a 2 µM aminated (at the 5ʹ-end) target
specific aptamer solution and 0.1% (v/v) triethylamine (TEA) for a duration of 12 hours. The
aptamers were covalently grafted to the surface bound PBASE molecules via amide bond
formation resulting from reaction with the primary amine on the probe aptamer [173], [181].
Successful coupling of PBASE to graphene and aptamer to PBASE was confirmed by Raman,
FTIR and UV-Vis analyses.

6.3.2.3.

Electrical Measurements

All electrical measurements were performed on a Micromanipulator (450 PM-B) probe station
using a PC-based LabVIEW program. A Keysight precision source/measure unit (B2902A) was
used for biasing as well as for supplying input voltages and measuring the output currents. The
drain-source voltage was maintained at 250 mV for all ID-VGS transfer curve measurements. The
liquid-gate voltage was linearly scanned from 0 V to 2.5 V with a voltage step of 12.5 mV using
the gate electrode. During each step, the VGS value was maintained for 1 second to stabilize ID to
ensure reliability of ID-VGS transfer curves resulting a scan rate of 12.5 mV/s. All the measurements
were performed with a fluid flow rate of 20 l/min. To evaluate the electrochemical effects on the
GFET devices, the leakage current at the gate electrode was also measured. The leakage current
IGS remained less than 1 µA and thus was considered negligible, as the magnitude of the ID was in
the range of 800 µA.

For the transient measurements of real-time monitoring of the aptamer-protein association and
dissociation, ID was measured by keeping VDS = 0.1 V. The gate source voltage (VGS) was also
fixed at a voltage near the charge neutrality point (i.e. VDirac) such that it locates in the linear region
of the ID-VGS transfer curve yielding a high value of transconductance, gm (See Figure C2 in
Appendix C). Here, the data points were collected once per second. Various concentrations of
thrombin were injected at a flow rate of 20 l/min for 1 hour. Afterward, a 0.01×PBS buffer was
flowed for another hour to dissociate and remove the bound protein biomarkers. Since GFETs can
only observe changes in the charge density that occurs within the distance similar to the Debye
length from the graphene surface, it is critical to ensure that the Debye length be sufficiently large.
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6.4.

Experimental Results and Discussion

6.4.1. Characterization of the surface functionalization
The interaction between PBASE and graphene via π-π stacking was characterized by Raman
spectroscopy. For the sample preparation, the GFET device was functionalized with 10 mM
PBASE in dimethyl formamide (DMF) for 2 hours followed by washing with DMF, ethanol and
DI water. The Raman spectra for both the bare graphene and the PBASE-treated graphene are
presented in Figure 6.3A. The G- and 2D- bands in the spectra indicate the presence of graphene
[182]. Moreover, the peak at 1618 cm-1 which is attributed to the pyrene group resonance peak due
to the π-π stacking interaction [79], [88] between the aromatic rings of the pyrene group of PBASE
and the basal plane of graphene which confirms the coupling of PBASE to graphene.

To characterize the crosslinking of aminated aptamers with PBASE, both the aptamers and PBASE
were reacted in a 3:2 mixture of tetrahydrofuran (THF) and PBS buffer. The aptamer-grafted
PBASE was purified by column chromatography and was allowed to dry an oven at 45ºC for 8 h.
The FTIR spectra of both dried PBASE-aptamer and pure PBASE powder are presented in Figure
6.3B where the presence of a strong peak at 1653 cm−1 (C=O stretching in the amide I) and the
broad stretching vibration peak around 3300 – 3550 cm−1 (N-H from the amide, O-H solely on the
DNA) confirm the amide bond formation [183]. By contrast, the corresponding peak for C=O in
PBASE appears at 1725 cm−1 and the absorption peaks at 1785 cm−1 and 1816 cm−1 are related to
the symmetric and asymmetric stretching vibration of the two C=O groups in the imide, while the
stretching peak for C-N in the imide appears at 1375 cm−1 .

After the PBASE and aptamer crosslinking was confirmed, the PBASE functionalized GFET
device was exposed to a 2 µM aminated (at the 5ʹend) target specific aptamer solution for 12 hours.
The sample was then washed with DI water and dried followed by UV-Vis spectroscopy
measurements. The UV-Vis absorption spectroscopy is shown in Figure 6.3C where the absorption
peak at around λ = 260 nm is a characteristic peak of the DNA oligonucleotides. This proves
successful immobilization of the aptamer receptor in the graphene channel.
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Figure 6.3. Characterization of linking of aptamer to GFET: (A) Raman spectrum (excitation by
532 nm) showing the coupling of PBASE to graphene; (B) FTIR spectrum showing the covalent
binding of aminated aptamer with PBASE; (C) UV-visible spectrum showing the final aptamer
crosslinking to PBASE/graphene; and (D) ID-VGS transfer characteristics showing the effects of
surface functionalization of the graphene.
We further investigated the functionalization-induced doping by measuring the ID-VGS transfer
curves of the microfluidic-GFET device before and after PBASE coupling. As can be seen from
Figure 6.3D, immobilizing PBASE linker to graphene causes the Dirac voltage to shift right. This
shift in the positive direction can be explained by the p-type doping effect due to the charge transfer
between PBASE and graphene [79], [88]. It is important to note that while the pyrene group of
PBASE is electron-rich and not expected to induce p-type doping to the graphene, the carbonyl
group of PBASE is an electron-withdrawing group that can cause electron transfer from graphene
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to the linker molecule [173], [184]. After PBASE functionalization, the devices were further
modified with DNA-based aptamer which caused the Dirac voltage to shift left with respect to the
position after the PBASE modification step. This is due to the n-type doping of graphene channel
by the electron rich nucleotide bases of the DNA aptamers acting as electron donors when
interacting with graphene [141], [142]. Using the shift in Dirac voltage, the aptamer density was
estimated to be 1.427 × 1011 /cm2 which is equivalent to 23.2 nm aptamer probe spacing (See the
Supplementary Information for the detailed calculation).

6.4.2. The FET-Based Sensing Experiments
6.4.2.1.

Control Experiments

To examine the inertness of the bare graphene to thrombin, a set of control experiments were
performed by exposing bare graphene to thrombin solution of various concentrations. As shown
in Figure C1(A) in Appendix C, no significant shift in the Dirac voltage is observed indicating a
non-responsive behavior of bare unmodified graphene to thrombin. We also performed another set
of control experiments to examine the adsorption behavior of thrombin on GFET device modified
with a different aptamer sequence. In this case, the graphene was modified with anti-lysozyme
aptamers and were exposed to different concentrations of thrombin solutions. The measured
transfer curves are presented in Figure C1 (B) which shows that there is no significant shift in the
Dirac voltage, indicating negligible non-specific adsorption of thrombin protein during the sample
flow.
6.4.2.2.

The Effects of Analyte Concentration on the Dirac Voltage Shift

Following the functionalization and aptamer immobilization, the GFET devices were exposed to
different concentrations of thrombin by delivering them through the microfluidic channel at 20
µl/min for 45 minutes each. Each sample exposure was followed by a washing step with 0.01×PBS
buffer for another 45 minutes for sensor regeneration. Figure 6.4A shows the ID-VGS characteristics
of the developed biosensor after exposure to different concentrations of thrombin protein.
Exposure to 1 pM of thrombin caused a Dirac voltage shift (ΔVDirac) of 101 mV in the positive
direction with respect to VDirac = 934.4 mV at 0 pM thrombin. With increasing concentrations of
the thrombin biomarker, VDirac continues to shift further to the right until it begins to saturate at
approximately 100 nM. This result is consistent with the cationic nature of thrombin protein at
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neutral pH [165], [166]. Upon binding of the thrombin to the anti-thrombin aptamer, the net
positive charge of the protein causes p-type doping of the graphene which explains the right-shift
of the Dirac voltage [27]. Figure 6.4B depicts the concentration dependent calibration curve
obtained by plotting the Dirac voltage shift (ΔVDirac) relative to the zero concentration of the
analyte (0 pM Thr). As indicated by the error bars in Figure 6.4B, fabricating reproducible GFET
devices is a challenge. This is primarily due to the variations in the graphene sheet in terms of the
graphene channel area as well as the defects and grain boundaries which can all have a significant
impact on the electronic properties of the film. However, the device reproducibility can be
improved by directly growing and patterning the graphene on the substrate rather than transferring
the film manually.

Figure 6.4. Performance of the microfluidic-integrated GFET biosensor: (A) ID-VGS transfer
characteristics of the GFET biosensor after exposure to different concentrations of thrombin
protein; (B) Concentration dependent calibration curve of the biosensor and its Hill-Langmuir fit
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(R2=99.25%). The sample set is 𝑛 = 3 and the error bar represents 1 standard error; (C) ID-VGS
transfer characteristics of the GFET thrombin biosensor after exposure to different concentrations
of lysozyme protein; and (D) Comparative bar chart showing the ΔVDirac of the GFET thrombin
sensor after exposure to different concentration of thrombin and lysozyme protein.

The calibration curve profile is best fitted by a model adapted from the Hill-Langmuir equation
that describes the equilibrium binding of a ligand by a receptor [137], [185], [186]:
∆𝑉𝐷𝑖𝑟𝑎𝑐 =

𝑥 𝑛
𝑉0 + 𝑉𝑚 (𝐾 )
𝐷

𝑥 𝑛
1 + (𝐾 )
𝐷

where 𝑉0 is the estimated minimum response with all binding sites empty, 𝑉𝑚 is the estimated
maximum response with all the binding sites occupied, 𝑥 is the target concentration, 𝐾𝐷 is the
effective dissociation constant that represents the concentration at which half of the available
binding sites are occupied, and 𝑛 represents the Hill coefficient.
The best fit (R2 = 0.9925) values are summarized in Table 6.1, where the Hill coefficient value of
n = 0.386 being less than 1 indicates a negative cooperativity in the binding of thrombin to the
GFET biosensor that may be due to the protein-protein interactions upon binding or increased
charge carrier scattering with increased ligand binding [137], [154]. The best fit value of KD =
375.8 ± 165.6 pM is in the similar range as reported previously [175], [187]. Based on the obtained
calibration curve, the calculated limit of detection (LOD) of our sensor is 2.6 pM (See Appendix
C for details).

Table 6.1. Summary of the Hill-Langmuir fitting parameters of the voltage calibration curve.
Hill-Langmuir

Value

Error

𝑽𝟎

39.2 mV

±30.6 mV

𝑽𝒎

418.2 mV

±20.8mV

𝑲𝑫

375.8 pM

±165.6 pM

𝒏

0.386

±0.081

parameters
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6.4.2.3.

Selectivity of the GFET Biosensor

The selectivity of the biosensor was tested against another common protein biomarker lysozyme.
For this experiment, the GFET device functionalized with thrombin-binding aptamer was exposed
to various concentrations (1, 10, 100, and 1000 nM) of lysozyme in 0.01× PBS buffer through the
microchannel and incubated for 45 minutes. The measured ID-VGS characteristic curves are
presented in Figure 6.4C. A comparative bar chart showing the Dirac voltage shift for both
thrombin and lysozyme is shown in Figure 6.4D. Exposure to high concentrations of lysozyme
does cause some degree of Dirac voltage shift possibly due to the protein either nonspecifically
binding to the anti-thrombin aptamer or directly adsorbing to the graphene surface. In either case,
the positively charged lysozyme [96] affects the doping level of the GFET (i.e. p-type doping) in
the same way the thrombin does to the device. However, its effect is relatively small compared to
that of thrombin of the same concentration, as shown in the chart.

6.4.2.4.

Real-Time and Transient Measurements

The transient FET measurements were performed on the device to monitor the protein-aptamer
interaction in real-time. Various concentrations (0 pM – 1 µM) of thrombin in 0.01× PBS were
added to the sensor for 1 hour. To check the selectivity of the sensor, the GFET was also tested
against a high concentration (1µM) of lysozyme for the same amount of time period. The signal
ID (t) was recorded while keeping VGS and VDS constant. The time-dependent measurements are
shown in Figure 6.5A. A gradually drifting background signal has been subtracted from ID (t). It
can be seen that for each concentration of thrombin exposure, ID (t) follows an exponentially
decreasing profile until PBS washing buffer was introduced to dissociate and remove the bound
thrombin. The figure also shows that there is minimal change in ID when exposed to lysozyme.
Figure 6.5B shows the enlarged view of the association and dissociation curves for the 1µM
thrombin concentration. After analyte injection into the microfluidic device, it took approximately
15 minutes for ID (t) to respond due to the time required for the liquid to reach the GFET. As soon
as the analyte reaches the sensor, target binding occurs and the signal drops exponentially until it
reaches a steady-state approximately after 35 minutes. The amount of drop (∆ID) in the drainsource current is plotted against the thrombin concentrations that result in the current calibration
curve in Figure C3 in the Appendix C. Table C2 in Appendix C summarizes the best fit (R2 =
0.9778) values of the Hill-Langmuir fitting parameters of the current calibration curve. The
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corresponding dissociation constant is found to be KD = 731.7 pM which is comparable to the
value obtained from the voltage calibration curve.

Figure 6.5. (A) The continuous real-time measurements of the GFET biosensor. The plot depicts
the transient measurement of the microfluidic-integrated GFET module biosensor. The liquid gate
was fixed at VGS = 0.75 V while the drain-source voltage was maintained at VDS = 100 mV. A
constant flow rate of 20 µl/min was maintained throughout the experiment. Data points were
collected every 1 second. A baseline drift of 9.378 nA/min has been subtracted from the curve.
Sharp spikes around the introduction of thrombin and the PBS buffer are noises associated with
switching of the syringes; and (B) Binding and unbinding process for the thrombin with
concentration of 1µM.
The selectivity of the sensor towards thrombin was again confirmed from this experiment as
introducing 1 µM lysozyme did not cause any significant change to the ID (t) signal. The sensor
can also be regenerated by simply rinsing with PBS buffer which has been confirmed by the
unbinding process and the baseline curve returning to the initial value to approximately 525 µA
shown in Figure 6.5B.

When recording the ID (t) measurement, the raw data exhibits a gradual upward drift over time.
This slow increase in the baseline current can be explained by the possible dissociation of pyrene
anchors from the graphene surface resulting in a loss of aptamers from the GFET [175]. This loss
of aptamers, although small in quantity, could shift the Dirac point in a positive direction causing
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ID (t) to rise (decrease of n-type doping) over time. However, this drift can be modeled using the
∆𝐼

formula: 𝑔𝑚 = ∆𝑉 𝐷 . In our devices, the measured baseline drift was ∆𝐼𝐷 = 9.378 nA/min which
𝐺𝑆

corresponds to a ∆𝑉𝐺𝑆 changing at a rate of 202 µV/min. At this rate, 50% of the aptamer coating
would dissociate after approximately 10 hours (i.e. the time to shift ∆𝑉𝐺𝑆 = 117 mV) which is
similar to the previously reported value [175]. The measurements in Figure 5 are the result after
baseline correction by subtracting the current drift.
6.5.

Conclusion

In conclusion, in this work, we have developed a microfluidic-integrated miniaturized GFET
biosensor module for selective detection of thrombin biomarker. Thrombin is often used as a model
protein in protein biosensing. It is also known for its several biomedical significances such as its
critical role in hemostasis and thrombosis, involvement in several cardiovascular diseases and
regulation of tumor growth. The binding affinity of the protein-aptamer interaction was quantified
with a dissociation constant value of 375.8 pM which was further confirmed by real-time thrombin
detection measurements. We also characterized the functionalization of aptamers on the GFET
surface by Raman, UV-Vis and FTIR spectroscopy techniques. The sensor is able to detect
thrombin as low as 2.6 pM.
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A FLEXIBLE PRINTED GFET FOR REALTIME MONITORING OF IL-6 PROTEIN
7.1.

Introduction

Graphene FET-based devices have proven to be very convenient for highly sensitive detection of
biomarkers as described in Chapter 5 and 6. Moreover, due to the planar structure with flexibility,
GFETs are highly suitable for flexible biosensors. In this chapter, I will describe how GFETs can
be fabricated on polymer based flexible substrates and demonstrate real-time detection of IL-6
protein, a well-known cytokine and a biomarker for immune responses, as a representative target
analyte [188], [189].

7.2.

Flexible GFETs in wearable electronics

Wearable electronics are usually flexible devices that can be worn or mated with human skin to
continuously and closely monitor an individual’s activities, without interrupting or limiting the
user’s daily routine. Therefore, wearable biosensors could enable real-time continuous monitoring
of an individual’s physiological biomarkers, that are essential to the realization of personalized
medicine for a variety of chronic and acute diseases [190], [191]. Essentially, wearable biosensors
should be designed in a manner so that it avoids the painful and risky blood sampling procedures
and can easily blend in with the user’s daily routine. This can be accomplished by providing a
direct contact between the biosensing platform and the biofluids (sweat, tears, saliva and interstitial
fluid) without inducing discomfort to the users [192].

Wearable biosensors have garnered substantial interest over the past decade, mainly concentrated
in the healthcare industry and are only capable of tracking an individual’s physical activities and
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vital signs (such as heart rate, blood pressure, skin temperature, etc.) and fail to provide insight
into the user’s health state at molecular levels. However, chemical analysis of biofluids could
enable such insight because it contains physiologically and metabolically rich information that can
be retrieved non-invasively. Sweat analysis is currently used for applications such as disease
diagnosis, drug abuse detection, and athletic performance optimization [190], [191]. It is the most
easily accessible biofluid for chemical sensing applications since sweat glands are distributed
across the entire body, with more than 100 glands/cm2 [192]. It is rich in physiological data,
containing electrolytes (such as sodium and potassium ions) and metabolites (such as lactate and
glucose). Under most climate conditions, an average adult human secretes between 500 to 700 ml
of sweat per day [193]. Therefore, sweat-based sensors can be applied in a variety of biomedical
and fitness applications.

Wang et al. from the Lin group of Columbia University developed an ultra-flexible and stretchable
GFET-based aptasensor for sensitive detection of TNF-α biomarker [194]. Presented in Figure 7.1,
this flexible GFET biosensor, which was built on Mylar substrate, demonstrated a high level of
mechanical flexibility and durability, as well as highly consistent electrical properties and
biomarker responses. However, the electrodes were deposited with metal evaporation and
patterned with conventional photolithography, thus making the fabrication process expensive and
complex. Moreover, sophisticated cleanroom environment and trained personnel are required for
the microfabrication of the GFET devices. All these issues can be addressed by printing the
electrodes using commercially available silver ink. Printing offers numerous advantages compared
to the microfabrication, such as flexibility and versatility in patterning, low-cost, rapid and mass
producibility as well as less wastage. Therefore, in this work, a benchtop PCB printer will be used
86

to print commercially available conductive silver ink on a flexible substrate and transfer graphene
on this printed electrode resulting in a printed flexible GFET. With this printed flexible GFET,
real-time detection of IL-6 protein biomarker will be demonstrated.

Figure 7.1. Ultra-flexible and stretchable GFET biosensor on flexible substrate. (a) Schematic of
the flexible device; (b) photographs of the ultra-flexible sensor conformably mounted on human
hand; (c) photograph of the nanosensor placed on a glass slide for biomarker detection; and (d)
Transfer characteristic curves measured when the nanosensor was exposed to TNF-α solution with
different concentrations. Reprinted from [194].

7.3.

Kapton® as flexible substrate for GFETs

Materials properties that are critical for a substrate in MEMS-based applications are the chemical
and thermal stability, flexibility, as well as vacuum compatibility [195], [196]. Device fabrication
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processes, such as physical deposition and etching require flexible substrate to experience high
temperature stress and vacuum. Cleaning agents such as acetone, isopropyl alcohol, or organic
solvents such as dimethyl formamide (DMF) are often used in photolithography and surface
functionalization of graphene FET based devices. Commonly used polymers used as flexible
substrates, such as poly(dimethylsiloxane) (PDMS), polyethylene terephthalate (PET) or
polyethylene naphthalate (PEN) can be vulnerable to these solvents. Polyimides can address these
issues due to their superior properties [196] as described below:
•

High thermal stability (up to 300ºC)

•

Highly chemical stability against commonly used solvents in the device processing

•

Low outgassing under high vacuum

•

Young’s modulus of 4GPa

Among other polyimides, Kapton® is selected as the flexible substrate because of its wide
availability. It is commercially available both in roll and in sheet format with standard thickness
of 0.0254 to 0.127 mm as seen in Figure 7.2.

Figure 7.2. Kapton® as a flexible substrate.

7.4.

Materials and Methods

7.4.1. Materials
The aminated aptamers having the specific affinity to mouse IL-6 (#ATW0077, KD=5.4 nM) and
the resuspension buffer were purchased from Base Pair Biotechnologies, Inc. (TX, USA). The
aptamer’s affinity has been thoroughly characterized by the manufacturer and is shown to be
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specific toward IL-6 proteins. IL-6 recombinant mouse protein was purchased from BioLegend
(San Diego, CA). PBASE (1-pyrenebutyric acid N-hydroxysuccinimide ester) was purchased from
Santa Cruz Biotechnology (TX, USA). Kapton® film (size: 12 inches × 12 inches, thickness: 1
mil) was purchased from Amazon.com, Inc.

7.4.2. Manufacturing of the printed GFET
The manufacturing of the printed GFET is presented in Figure 7.3. the manufacturing of the printed
GFET starts with designing the electrode pattern in an open-source CAD software KiCAD and
then printing it on a Kapton® film using Voltera V-One printer. Conductive silver ink was used
for printing the electrodes. Following printing, the printed film was sintered on a hotplate in order
to improve the adhesion between the ink and the film. Once the printed electrodes are sintered,

Figure 7.3. Manufacturing of printed GFET on Kapton® substrate.
a monolayer graphene film was transferred on the electrodes using a method known as “fishing.”
The transfer method was described in Figure 5.2 of Chapter 5. After the transfer, the protective
PMMA layer on top of graphene was removed by acetone and ethanol. The printed GFET device
on Kapton film with graphene transferred on it is shown in Figure 7.4. A PDMS microfluidic
channel was then integrated on the printed GFET for enabling real-time sensing.
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Figure 7.4. Printed GFET on Kapton®: (A) photograph showing the flexibility of the printed
GFET, and (B) enlarged view particularly showing the graphene monolayer transferred on the
electrodes.
7.4.3. Functionalization of the printed GFET
After manufacturing, the printed GFETs were functionalized with target (IL-6) specific aptamers
for using them as sensors. The functionalization process is schematically illustrated in Figure 7.5
where amine-linked aptamers are anchored on GFET using the PBASE linker via the wellknown NHS crosslinking reaction. The details have been described in Chapter 6.

Figure 7.5. Schematic showing the functionalization steps of the printed GFET.

7.5.

Experimental Results and Discussion

7.5.1. Characterization of the surface functionalization
The functionalization steps were characterized electrically using the GFET measurements. The
results are presented in Figure 7.6, where the relative shift of the Dirac voltage follows the same
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trend as our previous GFET devices on solid (SiO2/Si) substrate described in Chapter 6. This
demonstrates a successful functionalization of aptamers on the printed GFET on Kapton®.

Figure 7.6. Electrical characterization of the GFET functionalization: (A) ID-VGS transfer
characteristics curve at each functionalization strep, and (B) the bar graph showing the values of
VDirac for each functionalization step.
7.5.2. Real-time sensing of IL-6 using printed GFET
After successful functionalization of the printed Kapton GFETs (k-GFETs), they were utilized for
real-time sensing of IL-6 protein. For the real-time measurement, the GFET was biased at VGS =
100 mV and VDS = 750 mV. The binding between the aptamers and the proteins was monitored by
recording the changes in IDS while different concentrations (1, 10, 100 nM) of IL-6 protein in 0.01x
PBS+1mM MgCl2 were added to the sensor for 10 min each followed by a buffer incubation step
for sensor regeneration. The real-time measurements are presented in Figure 7.7. It can be seen
from Figure 7.7 that upon exposure of IL-6 protein, IDS decreases due to the association of the
aptamers and the target proteins. Moreover, when the buffer is introduced, IDS returns close to its
initial level due to the dissociation of the aptamer-protein complex.
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Figure 7.7. Real-time monitoring of IL-6 buffer: (A) transient measurements showing binding
and unbinding of aptamer-target, and (B) concentration dependent calibration curve.
7.6.

Conclusion

In this chapter, the feasibility of using Kapton® substrate based printed GFET for sensing of
protein biomarkers has been demonstrated. The electrodes were printed using a benchtop PCB
printer which makes the production easy, rapid, and low-cost enabling their use in point-of-care or
low-resources setting. Moreover, the use of Kapton® makes it compatible with wearable
electronics applications where flexibility is a critical component in the device design.
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AN ORGANIC SOLVENT-FREE
APTAMER IMMOBLIZATION METHOD ON GFET
PLATFORM
8.1.

Introduction

In recent years, graphene-based field-effect transistors (GFETs) and their uses as sensing platforms
have been greatly successful in developing various microfluidic and lab-on-a-chip-based
biosensors [197], [198]. Their effectiveness as a biosensing platform can be attributed to their high
carrier mobility, sensitivity to molecules, and 2-dimensional geometry resulting in ultra-sensitivity
and easy integration capability [199]–[201]. A GFET works based on the modulation of the
graphene channel conductance (i.e., the channel current) between the source and the drain upon
the application of an external electric field through the gate electrode. This principle can be
exploited as a method for sensing of biomolecules since charged molecules that are in close contact
with graphene (within the Debye length) will cause a change in the electric field leading to a
modulation in the drain-source current (IDS) of the GFET. A significant difference between GFETs
and other conventional FETs is their ambipolar transfer (IDS – VGS) curve which causes a minimum
channel current at the Dirac voltage also known as the charged neutrality point (VCNP). Any change
in the electric field induced by the adsorption of the charged molecules at the graphene surface
essentially causes a shift in the charge neutrality point enabling GFETs to be used for ultrasensitive detection of the target biomolecules [200], [202].

To enhance selectivity in analyte detection, GFETs are commonly integrated with bioreceptors
such as aptamers, antibodies and so forth. In this work, aptamers are used as the representative
target recognition probes. A major part of the implementation of such aptameric GFET devices is
the reliable immobilization of aptamer probes onto the graphene channel of the device. In general,
there are two main strategies for functionalizing aptamers on graphene, namely, the covalent and
the non-covalent immobilization approaches. While the covalent approaches offer certain
advantages over non-covalent methods in terms of stability and functionality, they unavoidably
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altar the physical properties of graphene. Hence, non-covalent modifications have been frequently
used in order to maintain the inherent properties of pristine graphene [203]. A typical non-covalent
attachment of aptamers on graphene involves a two-step method as shown in Figure 8.1A. In the
first step, a pyrene is anchored on the graphene via the π-π stacking interaction and in the second
step, the amine-terminated aptamers are attached to the pyrene via the EDC/NHS (1-ethyl-3-(3dimethylaminopropyl)

carbodiimide

hydrochloride/N-hydroxysuccinimide)

crosslinking

chemistry [204].

Figure 8.1. A schematic illustration of (A) a two-step aptamer functionalization on graphene
requiring the use of organic solvents to dissolve and disperse PBASE (1-pyrenebutyric acid Nhydroxysuccinimide ester), and (B) the proposed one-step modification process of aptamer probes
on GFET (Inset: the crosslinking of PBASE with an aminated aptamer to form a pyrene-tagged
DNA aptamer (PTDA) probe.
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A commonly used pyrene-based crosslinker, such as PBASE (1-pyrene butyric acid Nhydroxysuccinimide ester) as shown in Figure 8.1, requires organic solvents such as Dimethyl
formamide (DMF) or Dimethyl sulfoxide (DMSO) in order for it to be well-dispersed in a solution.
However, such solutions, being strong polar aprotic solvents, can dissolve most organic
compounds [205] and can become an issue for a number of applications especially in lab-on-achip and point-of-care diagnostic platforms [206]–[208]. Such devices often utilize thermo
plastics, flexible polymers, and passivation layers that are vulnerable to organic solvents resulting
in fluid leakage and other irreversible damages. Therefore, to circumvent these challenges, an
organic solvent-free aptamer immobilization method would be highly desirable and would also
allow more flexibility in choosing the materials in device fabrication. In this chapter, I explore the
feasibility of using an organic solvent-free aptamer functionalization technique where the aminelinked DNA aptamers are pre-tagged with pyrene groups. These pyrene-tagged DNA aptamers
(PTDA) are easily soluble in an aqueous buffer and can be anchored onto graphene surfaces
(Figure 1B) without the need of organic solvents. Wu et el. reported a GFET-based biosensor for
selective detection of E. Coli with the aid of pyrene-tagged DNA aptamers [83]. In their work, the
pyrene was incorporated during the synthesis process of the aptamers and the purification of the
aptamers was also conducted using column chromatography. Another GFET-based biosensor was
developed by Farid et al. for the detection of tuberculosis biomarker IFN-𝛾 using pyrene tagged
aptamers [209]. However, the aptamers were dissolved in DMF for diluting and immobilization
on GFET surface. Inspired by the previous developments, I propose in this work a cheaper and
simpler method to pyrene conjugation of the aptamers. Although pyrene conjugation on the
terminal of oligonucleotides has been well-established [210], the main novelty of this work is in
the use of such pyrene-tagged aptamers in the development of GFET-based protein biosensor.
Here, I demonstrate that GFET-based biosensors developed using aptamers pre-conjugated with
pyrenes are also effective in protein biomarker (IL-6) detection. In our approach, the PTDAs are
formed by crosslinking the pyrene groups to the commercially available amine-terminated
aptamers. Furthermore, to separate out the unreacted pyrenes, a simple purification is performed
by precipitation with the help of a centrifuge. Following the synthesis, the pyrene-tagged aptamers
are anchored onto the graphene surface. Moreover, the efficiency of the immobilization is
enhanced by applying an external electric field (E-field) to the GFET through the gate electrode
immersed in a PTDA solution (Figure 8.2). Generally, in the absence of an external electric field,
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the amount of the PTDAs anchored on the graphene surface is limited by the rates of diffusion and
mass transfer (Figure 8.2A (left)). However, by applying a negative electric field, the PTDA
molecules, which are negatively charged due to the combined effects of the electron-rich pyrenyl
groups and the negatively charged DNA strands, are pushed towards the graphene surface where
they interact with the graphene through the formation of π-π stacking interaction thereby enhancing
the immobilization rate and the surface coverage (Figure 8.2A (right)). This one-step
functionalization method also eliminates the need for additional washing steps and thus reduces
the time required for device fabrication. To demonstrate the effectiveness of our new technique in
GFET-based biosensor implementation, the developed platform is used to detect interleukin-6 (IL6) protein, a well-known cytokine and biomarker for immune responses, as a representative target
analyte [188], [189].

Figure 8.2. Schematic illustration showing the effect of applying an external electric field during
the functionalization of PTDA. (A) The distribution of PTDAs in the incubation buffer without
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and with the external electric field, and (B) device setup for applying the external E-field during
the PTDA functionalization on GFET.

8.2.

Materials and Methods

8.2.1. Materials
The aminated aptamers having the specific affinity to mouse IL-6 (#ATW0077, KD=5.4 nM) and
the resuspension buffer were purchased from Base Pair Biotechnologies, Inc. (TX, USA). The
aptamer’s affinity has been thoroughly characterized by the manufacturer and is shown to be
specific toward IL-6 proteins. The predicted secondary structure of the aptamer sequence is
presented in Figure 8.3A. PBASE (1-pyrene butyric acid N-hydroxysuccinimide ester) was
purchased from Santa Cruz Biotechnology (TX, USA). The GFET chip (GFET-S20) fabricated on
SiO2/Si was purchased from Graphenea, Inc. (San Sebastian, Spain). The gold electrodes
(source/drain) were passivated with insulating layers consisting of Al2O3 (50 nm)/Si3N4 (100 nm)
surrounding the electrode/graphene interface. A polydimethylsiloxane (PDMS) well (3 mm
diameter) was then integrated in-house to contain the liquid gate on the passivated area of the
electrode as well as to reduce liquid evaporation during measurements and incubation steps. Figure
8.3B, C shows the image of the GFET chip consisting of 12 individual GFET devices with a PDMS
well placed over the sensing area.

97

Figure 8.3. (A) Predicted secondary structure of the aptamer sequence purchased from Base Pair
Biotechnologies, Inc. (Product # ATW0077) and the photographs of (B) the GFET chip (12
individual GFETs per chip) with PDMS well on top; and (B) the enlarged view of the 3 GFET
devices of the chip (without the PDMS well). The source and drain electrodes are passivated with
an insulating layer while the in-plane gate electrode is fully exposed.
8.2.2. Formation of pyrene-tagged DNA aptamer (PTDA) probes
The crosslinking of the pyrene groups to the aptamers to form PTDAs is achieved by incubating
the aminated aptamers with PBASE dissolved in DMF following the protocol provided by the
aptamer manufacturer [211]. Briefly, 50 µL of 100 µM IL-6 binding amine-linked (at the 5՛ end)
aptamer in amine resuspension buffer is mixed with 1.26 µL of 10 mg/mL PBASE for 1 hour in
the dark. Then, 5 µL of 3 M sodium acetate is added to the aptamer/PBASE mixture followed by
the addition of 125 µL cold ethanol (100%). The mixture is then placed in the freezer for 25
minutes followed by centrifugation at 13000 RPM for 15 minutes causing a pellet formation as a
precipitate. The precipitate is collected by decanting the supernatant and then washed with 70%
ethanol followed by resuspension in 0.01X phosphate buffer saline (PBS). As per the manufacturer
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datasheet, the conjugation efficiency of the protocol varies from 50%–90%. Although the pellet is
expected to contain a very high yield of conjugated PTDAs, it also includes some unconjugated
aptamers or PBASE which can negatively impact the sensor performances. Also, there is the
possibility of multi-conjugated aptamers due to the interaction with amine groups in the
nucleobases. To obtain a precise yield of successful conjugation between aptamers and PBASE, a
more time-consuming analytical tools such as high-performance liquid chromatography (HPLC)
could be used to experimentally investigate the conjugation efficiency.

The concentration was determined by obtaining UV-Vis spectra measured with a Nanodrop
spectrophotometer. Figure D1 (Appendix D) shows the UV-Visible spectrum of the resuspended
PTDA. The peak at 260 nm corresponds to the presence of DNA nucleobases in the solution [212].
Although the UV-Vis spectrum is not able to provide the qualitative information about the
aptamers (i.e., whether it is denatured or intact) we anticipated that the majority of the aptamers
are in the properly functioning condition as evidenced by our GFET measurement results.
Afterwards, the PTDA solution was stored at 4 °C.

8.2.3. Immobilization of PTDA on graphene
For GFET functionalization and measurements, a PDMS well was constructed over graphene to
avoid evaporation of liquid. The solution containing PTDAs (2 µM in 0.01x PBS) was loaded into
the well and a negative electric field (-400 mV) was applied to the solution using a wire inserted
into the PTDA solution for 4 hours as shown in Figure 8.2B. Then, the GFET device was rinsed
with DI water to remove any unbound PTDA probes.

8.2.4. Selective detection of IL-6 protein
After functionalizing the GFETs with IL-6 binding aptamers, various concentrations (0.1, 1, 10,
and 100 nM) of IL-6 protein in 0.01x PBS with 2 mM MgCl2 was exposed to the sensing area for
10 minutes. To investigate the selectivity and specificity, 100 nM of lysozyme (Lys) protein was
also exposed to the IL-6 aptamer modified GFET in the same buffer.

8.2.5. Electrical measurements
For electrical measurements, the devices are placed on a probe station (Micromanipulator, 450
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PM-B) and a Keysight B2902A source/measure unit (SMU) is used to measure the ID–VGS transfer
characteristics. Voltage control and data acquisition are performed using a LabVIEW program.
During the measurement, the drain–source voltage (VDS) is biased at 100 mV and the drain current
(ID) was read while the liquid–gate voltage (VGS) was linearly scanned from 0 V to 1 V with a
voltage step of 12.5 mV using the in-plane gold gate electrode. A scan rate of 12.5 mV/s was
maintained so that ID is stabilized to ensure reliable measurements of the ID–VGS transfer curves.

8.3. Results and Discussion
8.3.1. Characterization of device performance and effect of gate materials
8.3.1.1. Mobility calculation of the GFET devices
The transfer characteristics of a transistor in a linear region can be described as follows [213]:
𝑰𝑫𝑺 =
Where,

𝑾
𝑳

𝑾
. 𝑪 . 𝝁. (𝑽𝑮𝑺 − 𝑽𝑪𝑵𝑷 ). 𝑽𝑫𝑺
𝑳 𝑻𝑮

is the width-to-length ratio of the GFET channel, 𝑪𝑻𝑮 is the total gate capacitance of the

liquid gate, 𝝁 is the carrier mobility. Figure 8.4A shows the ambipolar transfer characteristics of a
GFET resulting in a V-shaped curve where the left branch represents the increasing density of
positive charge carriers (holes) and the right branch represents the increasing density of negative
charge carriers (electrons) [214]. The critical transition voltage between the two regions where the
current reaches a minimum is called the charge neutrality point (VCNP) or the Dirac voltage (VD)
𝒅𝑰

[215]. The slope of the transfer curve (𝒅𝑽𝑫𝑺 ) in each region indicates the transconductance (𝒈𝒎 )
𝑮𝑺

for the hole and the electron, respectively and can be calculated by measuring the slopes of each
branch of Figure 8.4A. Mathematically, 𝒈𝒎 can be expressed as [216]:
𝒈𝒎 =

𝒅𝑰𝑫𝑺 𝑾
= . 𝑪𝑻𝑮 . 𝝁. 𝑽𝑫𝑺
𝒅𝑽𝑮𝑺
𝑳

Which leads to the following expression for mobility:
𝝁=

𝑳
𝒈𝒎
.
𝑾 𝑪𝑻𝑮 . 𝑽𝑫𝑺

Therefore, the average carrier mobilities for holes and electrons were calculated to be: 𝝁𝒉 =
𝟏𝟗𝟐𝟎 ± 𝟔𝟏 cm2/V/s and 𝝁𝒆 = 𝟐𝟒𝟕𝟓 ± 𝟏𝟔𝟑 cm2/V/s, where 𝑽𝑫𝑺 = 𝟏𝟎𝟎 mV and the value of 𝑪𝑻𝑮
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was taken to be 1.65 µF/cm2 [217]. This high values of the carrier mobilities indicate the suitability
of the GFETs for sensing applications.

Another important parameter that affects the sensitivity of the GFET devices is the on-off ratio
(ION/IOFF) of the drain-source current. The larger the value of the on-off ratio, the better the
sensitivity of the GFGET since the device will exhibit better immunity to noises. An on-off ratio
value of ~8 is calculated for the used devices which is above average for GFET devices grown by
a CVD technique [215].

7.3.1.2. Effect of gate materials on device characteristics
I also investigate the effect of different gate materials (Pt, Au, and Ag/AgCl) on the GFET transfer
characteristics illustrated in Figure 8.4B, C, D. Figure 8.4B shows the effects of the three gates
on the Dirac voltage or the charge neutrality point (VCNP) for the 6 GFET devices on a single chip.
As seen in the figure, Ag/AgCl gate electrode gives the lowest VCNP among the three gate
electrodes. However, the gold electrode provides the lowest device-to-device variations among the
devices on a single chip.

Figure 8.4C shows the effect of gate materials on gate leakage current where each bar represents
the RMS value of the leakage current (IGS) calculated from the IGS-VGS curves (See Appendix D).
The RMS value is calculated using the following equation:
𝟏
𝑰𝑮𝑺 = √ ∑ 𝒊𝟐𝑮𝑺
𝒏
𝒊

Where, 𝒏 is the number of measurement points, and 𝒊𝑮𝑺 is the leakage current for each individual
gate voltage.

Gate leakage has been a very common phenomenon in liquid-gate GFETs and is primarily caused
by the electrochemical redox reaction at the graphene/liquid interface resulting in an increased
current flow that negatively impacts the sensing performances of a sensor. Though passivation of
exposed electrodes can reduce the leakage current, carbon clusters and photoresist residues during
the wet transfer of CVD-graphene act as a source of carbon leading to redox current during IV
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scans [218], [219]. Among the three gate materials tested, Ag/AgCl results in the lowest gate
leakage.

Figure 8.4D shows the effect of gate materials on the hysteresis of GFET transfer characteristics.
Gate hysteresis or simply, hysteresis in GFET is the deviation of drain-source current upon reversal
of the gate voltage sweep direction [220]–[222]. This causes a shift in the charge neutrality points
in the forward and backward scans (See Appendix B). This shift (ΔVCNP,h) has been plotted in
Figure 8.4D for the three gate materials. It can be seen that Ag/AgCl gives the lowest hysteresis.

Though Ag/AgCl demonstrates the best performance in terms of operating voltage, gate leakage
and gate hysteresis, in-plane gold electrode is used throughout the experiments as it gives the
highest uniformity of the charge neutrality point among the devices on a single chip. Moreover,
the in-plane configuration of the gold electrode which can be fabricated at the same lithography
step as the golden source and drain electrodes enhance the compactness of the setup and allows
potential integration with the microfluidics platform [204].
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Figure 8.4. Characterization of GFET device performances and effect of gate materials. (A) GFET
transfer curve showing the calculation of transconductance, and bar charts showing the effect of
gate materials on (B) VCNP, (C) leakage current (rms value), and (D) gate hysteresis.
8.3.1.3. Characterization of successful functionalization of GFETs
The synthesized PTDAs were first characterized to verify the presence of an amide bond between
the PBASE and the aminated aptamer. The amide bond was characterized using the Fouriertransform infrared (FTIR) spectroscopy as presented in Figure 8.5A, where the presence of a strong
peak at 1653 cm−1 (C=O stretching in the amide I) and the broad stretching vibration peak around
3300–3550 cm−1 (N–H from the amide, –OH group at the 3ʹ end of the DNA) confirm the amide
bond formation [204]. Although amine groups from adenine, cytosine, guanine can also react with
the NHS ester of the PBASE linker resulting in amide bond, this efficiency of these reactions are
quite low compared with that with the primary amine group connected at the 5՛ end of the DNA
aptamer. Hence, it is expected that the amide peak at the FTIR is primarily attributed to the amide
bond at the 5ʹ end of the aptamer.
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Figure 8.5. Optical characterization of the one-step functionalization of aptamer probes on
graphene. (A) FTIR characterization of the amide bond of PTDA in dry state, and (B) Raman
spectrum (excitation by 532 nm) of three spots of PTDA functionalized graphene along with that
of a blank graphene (Gra).

After the amide bond was confirmed by the FTIR spectroscopy, the PTDAs were immobilized on
a bare graphene. The presence of the PTDAs on graphene was confirmed by Raman spectroscopy.
For Raman measurements, two samples were prepared, a blank graphene and a graphene
functionalized with PTDAs. The Raman spectra for the PTDA-modified graphene was taken at 3
different spots on the surface. Figure 8.5B shows the Raman spectra of the blank and the PTDAfunctionalized graphene where the G-band split at around 1628 cm-1 indicates the anchoring of the
PTDAs by π-π stacking interaction between the pyrene ring of the PTDA and the basal plane of
graphene [204].
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The anchoring of the PTDAs on graphene surface is also verified electrically by measuring the
GFET transfer curves before and after the probe attachment. As shown in Figure 8.6A, the charge
neutrality point shifts left upon PTDA immobilization on graphene. This negative shift is in
accordance with the negative charges on the DNA backbone and the electron-rich pyrene group of
the PTDA and is also consistent with the previous work by Wu et al [217]. Furthermore, the effects
of an external electric field can also be characterized using the IDS-VGS curves. Figure 8.6A further
shows that when a negative potential is applied at the gate, the PTDA immobilization efficiency
is enhanced which is reflected by the increased amount of the negative shift in the charge neutrality
point (VCNP) compared to the case without the external electric field. With a negative potential at
the gate, the negatively charged single-stranded PTDAs tend to migrate towards graphene surface
due to the electrostatic repulsion resulting in an increased density of the immobilized PTDA probes
[223]. Figure 8.6B shows the bar graph indicating the amount of shift in the VCNP with respect to
the blank GFET device for the two cases. With the electric field applied, the negative shift in the
charge neutrality point was measured to be 123.53 mV which is approximately 2.5 times larger
than that without the electric field.

Figure 8.6. GFET transfer curves showing the effect of external electric field on functionalization
of PTDA on GFET devices. (A) GFET transfer curves, and (B) the corresponding shift in V CNP
(n=5).
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8.3.1.4. Sensitivity and selectivity study of the sensor
After the successful functionalization of the GFET with the PTDAs, the device was exposed to IL6 proteins to characterize its sensing performances. Prior to IL-6 exposure, in order to test the
sensor’s selectivity to its target, the GFET-based IL-6 sensor was exposed to 100 nM of lysozyme
protein (a model interfering species) in 0.01X PBS with 2 mM MgCl2 for 10 minutes. Once the
selectivity of the IL-6 binding aptamers was confirmed, the sensor was then exposed to various
concentrations (100 pM, 1 nM, 10 nM, and 100 nM) of the target protein (IL-6) in the same buffer
and for the same exposure time. Figure 8.7A, B show the transfer curves and the bar graph,
respectively, for each sample exposure. These results indicate that our sensor platform is minimally
responsive to a non-target protein (lysozyme) even when a relatively large concentration (100 nM)
is exposed. By contrast, upon introducing 100 pM of the target biomarker IL-6 to the GFET sensing
area, the charge neutrality point shifts to the negative direction by a significant amount indicating
the specific analyte recognition by the aptamers as well as the target selectivity of the developed
IL-6 biosensor. The charge neutrality point continues to shift to the left with increasing
concentrations of IL-6 (Figure 8.7C). This consistent negative shift can be attributed to the n-type
doping of the graphene channel by the bound IL-6 proteins which have an isoelectric point of 4 ~
5.3 and therefore, is negatively charged under the buffer (pH=7.4) used in the experiment [224],
[225]. The basis of this target-induced doping of graphene is the target-induced conformational
change of the aptamers. In the absence of the target analytes, the aptamers anchored on the
graphene surface are in an unfolded, loop and flexible state. Upon exposure of the IL-6 targets,
target-induced conformational change of aptamers leads to a compact and stable state. These
structural changes of aptamers brings the negatively charged IL-6 protein to the close proximity
of the graphene surface, possibly resulting in a direct transfer (doping) of electrons from IL-6 to
graphene due to the π-π stacking interactions between the aromatic amino acids in IL-6 and the
basal plane of graphene [224].

Also, the specificity of sensor was examined by functionalizing the GFET with a random sequence
aptamer using the same protocol as the IL-6 aptamer and exposing different concentrations of IL6 protein. The results are presented in Figure D3 (Appendix D) which shows negligible shift in the
charge neutrality point after exposure to IL-6 protein. This further verifies that the IL-6 binding
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aptamer used in our sensor development exhibits specific target binding toward the IL-6
biomarker.

Figure 8.7. Sensing experiments with the GFET-based aptasensor: (A) the transfer curves, (B) the
bar chart showing the selectivity of the sensor (error bar with n=3); (C) transfer curves of the GFET
sensor when exposed to varying concentrations of IL-6; and (D) the concentration-dependent
calibration curve (n=3).
Figure 8.7D shows the calibration curve for a range of IL-6 concentrations obtained with a sample
size of n = 3. The device-to-device variations were addressed by normalizing the sensor response
(ΔVCNP) using the formula ΔVCNP/ΔVCNP,max, where VCNP,max is the charge neutrality
point corresponding to the maximum IL-6 concentration tested. The lowest concentration of 100
pM was detected with this method. However, increasing the number of washings steps (with 70%
ethanol) in the purification stage of the synthesis process and optimizing the incubation time may
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lead to increased sensitivity. Moreover, adjusting the buffer pH to make IL-6 positively charged
will increase the affinity between the positively charged IL-6 and negatively charged aptamer,
possibly leading to enhanced sensitivity. As an example, Figure 8.8 shows the IL-6 sensing result
and the corresponding calibration curve of the GFET-based biosensor in the same buffer (0.01x
PBS + 2 mM MgCl2) but with the pH adjusted to ~3.64.

Figure 8.8. Detection of IL-6 with the GFET-based biosensor under the pH of ~3.64: (A) IDS-VGS
transfer curves for different concentrations of IL-6 protein and (B) the corresponding
concentration-dependent calibration curve. The sample set is 𝑛 = 3 and error bar represents 1
standard error.

The limit of detection (LOD) of the GFET-based IL-6 sensor under this pH environment was
calculated to be ~8 pM which is an order of magnitude larger than that under the physiological pH
(pH ~7.4). Figure 8.8B also shows the Hill-Langmuir fit (See Appendix C) of the experimental
data. The sensing performances of the proposed sensor are comparable to other results published
in the literature. For example, Hao et al. have achieved a detection limit of 1.22 pM and a detection
range of 1 pM–1 nM using conventional aptamer immobilization methods [223]. From the HillLangmuir equation, the dissociation constant KD is estimated to be 3.4 nM, similar to the value
(5.4 nM) reported by the manufacturer for the aptamer-target pair.
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8.4. Testing in Artificial Sweat
To verify the applicability of the sensors in real samples, the sensors must be tested in real samples.
As an initial step, the sensor was tested in diluted artificial perspiration (pH=7.4) purchased from
Pickering Solutions. As the perspiration is highly viscous, it was first diluted 10 times using 0.01x
PBS in 1mM MgCl2 and this diluted perspiration was spiked with different concentrations of IL-6
protein which was exposed to the GFET sensor. The results are presented in Figure 8.9. With the
Dirac voltage shifted consistently with increased concentration of IL-6 spiked in artificial
perspiration, it is clear that the sensor is able to detect IL-6 in artificial sweat referring to its
potential applicability in real human sweat.

Figure 8.9. Detection of IL-6 in artificial perspiration. (A) GFET measurements showing relative
shift for different concentrations of IL-6 spiked in diluted artificial perspiration, and (B)
corresponding bar chart showing the shift of the Dirac voltage.

8.5. Conclusion
In this chapter, I develop a facile and rapid immobilization technique to attach target recognition
probes on the GFET-based biosensing platform. The developed sensor is able to selectively
measure IL-6 protein biomarker with the detection limit in the picomolar range. The sensitivity
can be further improved by increasing the incubation time, purification steps as well as by adjusting
the buffer pH to an acidic region. The proposed organic solvent-free aptamer immobilization
technique is not only polymer friendly (and therefore allows more flexibility in device design and
fabrication) but also simplifies and shortens the graphene modification process by eliminating the
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extra step needed for anchoring the linker molecules and the subsequent washing steps. I also
demonstrate that an external electric field can be used to enhance the efficiency (~2.5 times) of the
aptamer immobilization on the graphene surface. My proposed technology has the potential to be
used in monitoring IL-6 from real physiologically relevant fluid samples such as sweat, serum and
cerebrospinal fluid.
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CONCLUSION AND FUTURE WORK
8.1. Summary of Contributions
The main contributions of this dissertation in the field of nanoelectronic device-based biosensors
are briefly described as follows:
A. The use of inkjet-printing in manufacturing low-cost electrochemical biosensors was
presented (Chapter 4). Inkjet-printable ink based on CNT and aptamer mixture was
prepared and printed on disposable screen-printed carbon electrode using drop-on-demand
inkjet printer. We have shown that printing of CNT-based ink can be used as a means for
immobilizing aptamers on the electrode contrary to the commonly used chemistries which
are often time consuming, lacks control on packing density, as well require laboratory
settings with trained personnel. The inkjet-printed biosensor not only addresses the issues
in the conventional aptamer immobilization methods, but also demonstrates comparable
performances with the conventional electrochemical biosensors in terms of sensitivity,
selectivity, and shelf-life.
B. A protein biomarker Lysozyme was detected using a CVD grown graphene FET for the
first time (Chapter 5). The liquid-gated GFET device was able to selectively detect
lysozyme with nanomolar limit of detection.
C. An integrated GFET platform was developed to detect another protein biomarker Thrombin
with picomolar limit of detection (Chapter 6). This was done by integrating the GFET
device with microfluidic channel which eliminates the measurement inaccuracy introduced
by evaporation and thus improves the sensitivity. Moreover, the compactness of the
platform was enhanced by replacing the conventionally suspended gate electrode with an
in-plane photolithographically-patterned gate electrode. Also, real-time continuous
detection of Thrombin was demonstrated and verified with discreate measurements.
D. A flexible GFET platform was developed using a PCB printed electrode on flexible
polyimide (Kapton®) substrate. Graphene transfer protocol for the rigid SiO2/Si substrate
was tailored considering the thermal and chemical stability of the flexible substrate. Realtime detection of a sweat-based protein interleukin-6 (IL-6) was also demonstrated using
this flexible printed GFET device (Chapter 7).
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E. The limitations of the conventionally manufactured electrode design were addressed by
adopting a printing-based electrode fabrication method (Chapter 7). Conventionally,
electrodes are manufactured using microfabrication techniques which require costly
microfabrication setup, sophisticated cleanroom environment as well as trained personnel
limiting the affordability of the sensors in point-of-care applications. However, the
proposed device electrodes printed with a benchtop PCB printer not only addresses the
above-mentioned issues but is also compatible with applications requiring flexible
substrates. This enables the development of a wearable biosensor for real-time continuous
monitoring of individual’s health.
F. A facile and rapid aptamer-immobilization method was developed for functionalizing
GFET devices without the need of any organic solvents such as dimethyl formamide
(DMF) or Dimethyl siloxane (DMSO). These organic solvents often used in the
conventional aptamer immobilization method on GFET are generally not compatible with
the polymer-based substrates as well as the fluidic tubings and channels for flexible and
lab-on-a-chip based sensing devices. Therefore, this organic solvent-free immobilization
method can address these challenges by eliminating the use of such organic solvents
(Chapter 8).
G. The effects of various gate materials (Pt, Au, Ag/AgCl) on the GFET measurements were
investigated. It is found that among the three gates, Ag/AgCl demonstrates the best
performance in terms of operating voltage, gate leakage and gate hysteresis, while in-plane
gold electrode results in the most stable charge neutrality point (Chapter 8).

8.2. Future Work
The sensors developed in this work has great potentials for health care monitoring, especially for
point-of-care diagnostics and personalized medicine. However, before field deployment of these
devices can become a reality, certain challenges still remain to be addressed. The following are the
future research directions needed in order to render these sensing platforms field deployable.

8.2.1. Real-sample analysis
Though novel contributions have been made towards developing nanoelectronic device-based
biosensing platforms, real physiological samples have not been used to evaluate the sensors.
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Though the sensors passed the selectivity test performed by adding a limited number of interferants
into the buffer, real-sample analysis is of paramount importance to make sure that the developed
sensors function properly with human samples such as serum, saliva, etc. as real human samples
contain thousands of interferants that could reduce the signal-to-noise ratio (SNR). The sensors
should be equipped with interferant-rejecting mechanisms such as coating materials or blocking
agents [226] that could prevent non-specific adsorption (NSA) leading to an increase in the
sensor’s inertness to non-target interferants. For example, Wang et al. employed a polymer coating,
namely polyethylene glycol (PEG), to functionalize GFET surface for preventing NSA for
aptamer-based detection of IgE protein in human serum [91]. However, the PEG modified GFETs
experienced significant reduction in the transconductance [227], thus negatively affecting the
sensitivity. Therefore, novel NSA reduction methods without affecting sensing performances
should be developed.

8.2.2. Flexible printed GFET
Though printed Kapton® GFET has been shown to be effective for real-time sensing of IL-6
biomarkers. Possible modifications for improving the performance of the printed GFET are
discussed in this section.

Choosing the right flexible substrate could be one future direction of research for improving the
performance of the flexible GFET. Though Kapton® stands out as one of the best flexible substrate
in terms of their chemical and thermal stability to tolerate the heating steps in the manufacturing
processes, there are a few drawbacks associated with this material. One of them is the poor
adhesion of the printed electrodes that causes the electrodes to peel off from the substrate. Though
high temperature sintering can address the issue to some extent, it might affect the substrate’s
thermal stability. Therefore, other polymer materials should be investigated to solve this issue. For
example, Liang et al. used polyethylene naphthalate (PEN) substrate (Teonex® Q65 film) for
developing a flexible GFET [228]. In another example, Mylar was used for developing a flexible
and stretchable GFET for detection of TNF-α [194]. The decreased carrier mobility due to the
unwanted doping induced in graphene by the flexible substrates should also be considered. This
could be solved using an additional coating of dielectric like SiO2 over the flexible substrate [229].
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Another area for improvement in the printed GFET of this work is the lack of stretchability due to
the cracking of the printed electrodes. Therefore, development of a highly conductive and
stretchable ink is needed.
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APPENDIX A
A.1. Calculation of Printed Volume of CNT-Aptamer Ink
4.0 mm

Number of droplets printed on a 4 mm length = 20×10−3 mm = 200
Total number (#) of droplets in the 4 mm square = (200)2 = 40,000
# of droplets in the 4mm diameter circular electrode =

πr2
d2

d

× 40000 = 31416, where r = 2

Hence, the amount of ink per layer printed on the electrode = 31416 × 10 pL = 0.31416 µL ≈
315 nL.
A.2. Lysozyme Binding Confirmation
To confirm that lysozyme binds to the aptamer, we performed lysozyme binding experiments with
MB-labelled thiolated DNA aptamers on gold rod electrode. The electrochemical DNA-based
lysozyme sensor was fabricated on a 3 mm gold rod electrode (A-002421, Bio-Logic USA Science
Instruments, TN, USA) using a previously described method [244]. The experiments were
performed using Ag/AgCl as the reference electrode and platinum as the counter electrode. The
results are presented in Figure A2.

(a)
(b)
Figure A2. Square wave voltammograms obtained for different concentrations of lysozyme in
10 mM PBS buffer.

It can be seen that, when lysozyme is exposed to the aptamer-modified gold electrode, the peak
current reduces until it reaches saturation for higher concentration of lysozyme. These results
suggest specific binding of lysozyme to the aptamer-based recognition element [245], [246].
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In the absence of lysozyme, the MB-labelled aptamer probes are relatively flexible; allowing the
attached MB to collide with the electrode that enables efficient electron transfer from the MB to
the electrode. This is in accordance with the relatively high voltammetric peak current for the
reversible reduction of MB as characterized using square wave voltammetry (SWV). When
lysozyme binds to the aptamer due to the specific affinity, the aptamer undergoes conformational
change that alters the electron tunneling distance hindering the charge transfer from the MB to the
electrode. As a result, the voltametric peak current decreases.

A.3. Chronocoulometric Experiments
To perform chronoloculometry, the printed sensor was incubated in 1mM RuHex in 10 mM TrisHCl solution for 1 h. During the incubation, RuHex ions electrostatically bind to the negative
backbones of the DNA aptamers. The number of probe molecules are thus proportional to the
number of bound RuHex ions to the DNA probes. After RuHex incubation, the electrode is then
washed thoroughly in DI water to remove the unbound RuHex ions.

We first characterized the redox reaction of RuHex at the printed electrode using cyclic
voltammetry (CV). The CV curves are presented in Figure A3(a) before and after the RuHex
incubation. The two CV peaks with almost zero peak separation in the presence of RuHex indicates
the electrostatically bound RuHex ions to the backbones of the surface-confined DNAs [247].
Figure A3(b) displays the CC curves at the printed electrode in the presence and absence of 1 mM
RuHex. QSE is obtained from the CC intercepts at t = 0 and the surface density of probe DNAs can
be calculated using Equations (4) and (5) in Section 3.3 where z = 3 and m = 30 in our case.

(a)

(b)
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Figure A3. (a) Cyclic voltammograms (scan rate: 500 mV/s); and (b) CC responses curves of
printed electrode in the presence (red) and absence (black) of RuHex.
A.4. LOD Calculation
The limit of detection (LOD) can be calculated by the following equation [248]:
𝜇𝑔
3.3 × 𝑆𝑡𝑎𝑏𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 0 𝑚𝐿 𝐿𝑦𝑠 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
𝐿𝑜𝐷 =
𝜇𝑔
𝑆𝑙𝑜𝑝𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑐𝑢𝑟𝑣𝑒 𝑎𝑡 0 𝑚𝐿 𝐿𝑦𝑠 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
=

3.3× 1.97
71.89 𝑚𝐿/𝜇𝑔

= 90.4 ng/mL

A.5. Effect of number of printed layers on sensor responses

Figure A4. Comparison of the sensor responses as a function of the different printing layers.
Each sensor was exposed to 1 µg/mL of lysozyme protein.
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APPENDIX B
B.1. Lysozyme Binding Confirmation
Lysozyme binding to the aptamers was confirmed by performing experiments with methylene blue
(MB)-labelled thiolated DNA aptamers (LGC Biosearch Technologies, CA, USA) with the same
sequence as used by Ellington et al. [122] on gold rod electrode. The DNA-based electrochemical
lysozyme sensor was fabricated on a gold rod electrode (A-002421, Bio-Logic USA Science
Instruments, TN, USA) of 3 mm diameter using a previously described method [244]. The
experiments were performed in a 3-electrode electrochemical cell with Ag/AgCl as the reference
electrode and platinum as the counter electrode. The results are presented in Figure B1.

Figure B1. Square wave voltammograms obtained for different concentrations of lysozyme in
0.01X PBS.

It can be seen from Supplementary Figure B1 that the peak current reduces when lysozyme is
exposed to the aptamer-modified gold electrode which suggests that specific binding of lysozyme
to the aptamer-based recognition element has occurred [245], [246]. In the absence of lysozyme,
the MB-labels are easily accessible to the electrode which enables efficient electron transfer
between the MB and the electrode. This causes high voltammetric peak current for the reduction
of MB as characterized using square wave voltammetry (SWV). When lysozyme comes in
proximity to the aptamers, due to the specific affinity the aptamers undergo conformational change
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to capture the proteins. This alters the electron tunneling distance hindering the charge transfer
from the MB to the electrode. As a result, the voltammetric peak current decreases.
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APPENDIX C
C.1. Device Fabrication
C.1.1. Graphene transfer
To transfer graphene onto the substrate, the monolayer graphene on polymer film was immersed
in deionized water slowly while the graphene film protected by the sacrificial layer was detached
from the support polymer film and remained floating on the water. The floating sacrificial
layer/graphene layer was then collected by the patterned gold electrode substrate which was then
dried at room temperature for 30 minutes followed by annealing on hot plate at 150 C for 1 hour.
To remove the top sacrificial layer, the sample was then treated with acetone for 1 hour followed
by dipping into ethanol for another 1 hour. Finally, the sample was dried with an air gun and
thermally annealed in an oven at 300 C in argon atmosphere for 2 hours.
C.1.2. Microfluidic channel fabrication
The microfluidic channel was fabricated with a PDMS block using the cast molding technique
[180]. For this, an SU-8 (MicroChem Corp.) master mold with the desired channel pattern (width:
600 µm, height: 100 µm) was formed on silicon wafer surface. The degassed mixture of PDMS
prepolymer and curing agent (Sylgard 184) mixed at a weight ratio of 10:1 was poured on the
prepared master mold. Then the PDMS block was cured at 60 C for 4 hours and then peeled off
from the SU-8 mold.
C.2. GFET Devices Labels
Table C1: Summary of the labels for the 6 GFET devices in the microfluidic-integrated GFET
device.
Device #

Source/Drain
electrodes
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Gate electrode

GFET- 1

2/3

1

GFET- 2

3/4

1

GFET- 3

4/5

1

GFET- 4

6/7

10

GFET- 5

7/8

10

GFET- 6

8/9

10

C.3. Aptamer Packing Density Estimation
The change of surface charge (ΔQ) can be expressed as [197],
∆𝑄 = 𝐶 × ∆𝑉𝐷

(1)

Where, ∆𝑉𝐷 is the shift in Dirac voltage, and 𝐶 is the total gate capacitance, which can be
expressed in by the following equation [197]:
1
𝐶

1

=𝐶

𝐺1

1

+𝐶

𝐺2

1

+𝐶

(2)

𝑄

Where, 𝐶𝐺1 and, 𝐶𝐺2 are the geometrical capacitances formed due to the electrical double layer
capacitances on different interfaces and denote the capacitance between the graphene and solution,
and the capacitance between the gate electrode and solution, respectively. 𝑑1 and 𝑑2 represent the
plate distances for 𝐶𝐺1 and 𝐶𝐺2 , respectively where 𝑑1 = 𝑑2 = 𝑑 = Debye length. 𝐶𝑄 which is
related to the Fermi level shift, denotes the quantum capacitance of graphene associated with finite
density of states due to Pauli principle [230].
From the model of parallel plate capacitors, we can write the following expressions for 𝐶𝐺1 and
𝐶𝐺2 .

𝐶𝐺1 =

𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 𝜀𝑟 𝜀0
𝑑

and 𝐶𝐺2 =

𝑆𝑔𝑎𝑡𝑒 𝜀𝑟 𝜀0
𝑑

where, Sgraphene is the contact area between the electrolyte and graphene monolayer, Sgate is the
contact area between the electrolyte and gold gate electrode, 𝜀0 is the vacuum permittivity
(8.854 × 10−12 𝐹/𝑚) and 𝜀𝑟 is the relative dielectric constant of PBS solution (80). Estimated
Debye length for a 0.01× PBS buffer concentration, 𝑑 = 7.3 𝑛𝑚.

Sgraphene can be expressed as:
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𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 = 𝐿𝑔𝑓 × 𝑊𝑚𝑐
where, Lgf is length of the graphene film which equals to 5 mm or 5000 µm and Wmc is the width
of the microfluidic channel that equals to 600 µm. Therefore,
𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 = 3,000,000 µ𝑚2 .
Similarly, Sgate can be expressed as:
𝑆𝑔𝑎𝑡𝑒 = 𝐿𝑔𝑎𝑡𝑒 × 𝑊𝑚𝑐
where, Lgate is the width of each gate electrode which equals to 100 µm and Wmc is the width of
the microfluidic channel that equals to 600 µm. Therefore,
Sgate= 100×600 =60,000 µm2.

Therefore, the geometrical capacitance values can be calculated as:
𝐶𝐺1 =

𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 𝜀𝑟 𝜀0 3,000,000×10−12 ×80×8.854×10−12

𝐶𝐺2 =

=

𝑑

7.3×10−9

𝑆𝑔𝑎𝑡𝑒 𝜀𝑟 𝜀0 60,000×10−12 ×80×8.854×10−12
𝑑

=

7.3×10−9

= 291.1 nF

= 5.822 nF

The total geometrical capacitance (CTG) can be calculated as the series combination of 𝐶𝐺1 and 𝐶𝐺2
and the value yields, 𝐶𝑇𝐺 = 57.08 𝑛𝐹.
The quantum capacitance CQ can be expressed as:
𝐶𝑄 = 𝐶𝑞× 𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒
where Cq is the quantum capacitance per unit area and the value is ~ 2 µF/cm2 [197] . Therefore,
𝐶𝑄 = 0.6 nF.

Now, the total gate capacitance, C can be calculated from Equation (2) as: C= 0.593 nF.

From Figure 6.3D, the attachment of 27-mer thrombin-binding aptamer leads to a Dirac voltage
shift, ΔVDirac= 403.9 mV.
So, ∆𝑄 = 𝐶 × ∆𝑉𝐷 = 0.593 × 10−9 × 403.9 × 10−3 = 2.4 × 10−10 C.
If the probe density is 𝑛, ∆𝑄 can be written as:
∆𝑄 = 27𝑛𝑒𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒
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 𝑛=

∆𝑄

=

2.4×10−10

27𝑒𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 27×1.6×10−19 ×3000000×10−12

=1.85 × 1013 /𝑚2 = 1.85 × 109 /𝑐𝑚2 .

Therefore, the aptamer probe density can be estimated to be 1.85 × 109 /𝑐𝑚2 . This is equivalent
to 232 nm aptamer probe spacing which is comparable to other reported values in literature [154].

C.4. Control Experiments
To examine the inertness of the bare graphene to thrombin, a set of control experiments were
performed by exposing bare graphene to thrombin solution of various concentrations. The
measured transfer curves are presented in Figure C1. It can be seen that there is no significant shift
in the Dirac voltage, indicating non-responsive behavior of bare unmodified graphene to thrombin.

Figure C1: Control experiments. ID-VGS transfer curves of (A) bare graphene, and (B) lysozyme
(LYS) aptamer modified graphene exposed to different concentrations (from 1 pM to 1 µM) of
thrombin.

C.5. Calculation of Limit of Detection (LOD)
Limit of detection can be calculated according to the following equation:
𝐿𝑂𝐷 =
=

3.3 × 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑡ℎ𝑒 𝑙𝑜𝑤𝑒𝑠𝑡 𝑐𝑜𝑛𝑐𝑒𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑
𝑆𝑙𝑜𝑝𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑐𝑢𝑟𝑣𝑒

3.3×11.8521
14.8715

=2.63 pM

C.6. Calculation of the Transconductance, gm
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Figure C2. Calculation of transconductance
C.7. Current Calibration Curve from Transient Measurements

Figure C3. The concentration-dependent drain current (ID) calibration plot and its Hill-Langmuir
fit curve (R2 = 97.78%).
The data can be fitted by the same Hill-Langmuir equation in the current domain:
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∆𝐼𝐷 =

𝑥 𝑛
𝐼0 + 𝐼𝑚 (𝐾 )
𝐷

𝑥 𝑛
1 + (𝐾 )
𝐷

Table C2 summarizes the best fit (𝑅 2 =0.9778) values of the Hill-Langmuir equation. It gives a
dissociation constant of 𝐾𝐷 = 0.7317 nM which is comparable to the value obtained from the
voltage calibration curve.
Table C2. Summary of the Hill Langmuir fitting parameters of the current calibration curve in
Figure C3.
Hill-Langmuir

Value

Error

𝑰𝟎

-0.1729 µA

±2.6456 μA

𝑰𝒎

5.6025 µA

±2.3776 μA

𝑲𝑫

0.7317 nM

±1.8664 nM

𝒏

0.2070

parameters
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±0.2193

APPENDIX D
D.1. Confirmation of the presence of DNA nucleobases in the synthesized product

Peak @ 260 nm

Figure D1. UV-visible spectrum of the pyrene tagged DNA aptamer. The peak at 260 nm is the
characteristic DNA peak that corresponds to the presence of DNA nucleobases in the synthesized
product.

D2. Leakage current and hysteresis in the GFET transfer curve

Figure D2. Measurement data for a gate (Pt) electrode: (A) gate leakage (IGS) vs gate-source
voltage (VGS), and (B) IDS-VGS transfer curve showing the amount of hysteresis (ΔVCNP,h).
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D3. Hill-Langmuir fitting of aptamer-protein equilibrium binding
The calibration curve profile presented in Figure 8.8 can be best modeled by the Hill-Langmuir
equation that describes the equilibrium binding of a ligand by a receptor [231]–[233]:
𝑟=

𝑐 𝑛
𝑟0 + 𝑟𝑚 (𝐾 )
𝐷

𝑐 𝑛
1 + (𝐾 )
𝐷

where 𝑟0 represents the estimated minimum response while all the binding sites are empty, 𝑟𝑚 is
the estimated maximum response while the binding sites are occupied, 𝑐 indicates the target
concentration, 𝐾𝐷 is the effective dissociation constant which is defined as the concentration where
half of the available binding sites are occupied, and 𝑛 represents the Hill coefficient.
Table 1 summarizes the values of the parameters that result in the best fit (R2 = 0.9925) for the
Hill-Langmuir model of the calibration curve. A Hill coefficient value of n = 0.3 (which should be
close to 1 under ideal conditions) indicates a decreased binding affinity with the target which may
be caused by the interactions among the neighboring proteins or by the increased charge carrier
scattering as more ligand bindings occur on the graphene surface [137], [234]. The best fit value
of KD = 3.4 ± 2 nM is nearly identical to the value reported by the aptamer manufacturer. Based
on the obtained calibration curve, the limit of detection (LOD) of our sensor is calculated to be ~8
pM.

Table 1: Summary of the Hill-Langmuir fitting parameters of the calibration curve.
Hill-Langmuir

Value

Error

𝒓𝟎

-9.6 %

±3.1 %

𝒓𝒎

179.4 %

±18.6 mV

𝑲𝑫

3.4 nM

±2 nM

0.3

±0.03

parameters

𝒏

D4. Specificity test with a random sequence aptamer
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To test the specificity of the GFET sensor, the GFET was functionalized with a randomized
aptamer sequence using the same one-step functionalization protocol as the IL-6 aptamer. The
sequence

of

the

randomized

single-stranded

DNA

was:

ATCAGGGCTAAAGAGTGCAGAGTTACTTAG. Following functionalization, the aptamer
modified GFET was exposed to different concentrations (1, 10 and 100 nM) of IL-6 protein. The
results are presented in Figure D3, which shows no significant shift of the charge neutrality point
upon exposure of the IL-6 protein. This is due to the fact that the random sequence aptamer does
not exhibit high affinity toward IL-6 protein suggesting the specificity of our sensor toward the
target protein IL-6.

Figure D3: Scramble aptamer test: (A) GFET measurements of the scramble aptamer modified
GFET upon exposure of different concentrations of IL-6 protein, and (B) Comparative bar chart
showing the response of IL-6 protein to the aptamer-modified GFET.
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